Processing 00000000.tx.1: Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* Hideaki Kaneto, Gang Xu, Nobuharu Fujii, Shokei Kim, Susan Bonner-Weir, and Gordon C. 

Phrase: "Involvement of c-Jun N-terminal Kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in Oxidative Stress-mediated Suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0221103:Suppression [Pathologic Function]
   812   C0301625:Suppression [Organism Function]
   812   C0439181:% suppression [Quantitative Concept]
   812   C0728721:suppression [Mental Process]

Phrase: "of Insulin Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "* Hideaki Kaneto,"

Phrase: "Gang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680397:gang [Population Group]

Phrase: "Xu,"

Phrase: "Nobuharu Fujii,"

Phrase: "Shokei Kim,"

Phrase: "Susan Bonner-Weir,"

Phrase: "and"

Phrase: "Gordon C."
Processing 00000000.tx.2: Weir** From the Section on Islet Transplantation and Cell Biology and Section on Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215and the Departmant of Pharmacology, Osaka City University Medical School, Osaka 545,Japan Received for publication, March 1,2002, and in revised form, May 10,2002  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Oxidative stress, which is found in pancreatic -cells in the diabetic state, suppresses insulin gene transcription and secretion, but the signaling pathways involved in the -cell dysfunction induced by oxidative stress remain unknown. 

Phrase: "Weir"

Phrase: "*"

Phrase: "*"

Phrase: "From the Section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "on Islet Transplantation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079646:Transplantation, Islet [Therapeutic or Preventive Procedure]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]

Phrase: "and"

Phrase: "Cell Biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Section on Metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02215and"

Phrase: "the Departmant of Pharmacology,"

Phrase: "Osaka City University Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   804   C0036375:School [Manufactured Object,Organization]

Phrase: "Osaka 545,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 1,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 10,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "found in pancreatic -cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the diabetic state,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "and"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "but"

Phrase: "the signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "involved in the -cell dysfunction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "induced by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0205263:Induced [Functional Concept]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "remain"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.3: In this study, subjecting rat islets to oxidative stress activates JNK, p38 MAPK, and protein kinase C, preceding the decrease of insulin gene expression. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "subjecting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "rat islets to oxidative stress"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the decrease of insulin gene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.4: Adenovirus-mediated overexpression of dominant-negative type (DN) JNK, but not the p38 MAPK inhibitor SB203580 nor the protein kinase C inhibitor GF109203X, protected insulin gene expression and secretion from oxidative stress. 

Phrase: "Adenovirus-mediated overexpression of dominant-negative type (DN) JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the p38 MAPK inhibitor SB203580"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   795   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   747   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   747   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   726 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nor"

Phrase: "the protein kinase C inhibitor GF109203X,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protected insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretion from oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
Processing 00000000.tx.5: Moreover, wild type JNK overexpression suppressed both insulin gene expression and secretion. 

Phrase: "Moreover,"

Phrase: "wild type JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "both insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.6: These results were correlated with changes in the binding of the important transcription factor PDX-1 to the insulin promoter; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "correlated with changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1707520:Correlated [Qualitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of the important transcription factor PDX-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   888   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   888   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1826562:PDX-1 [Gene or Genome]
   804   C0040649:Transcription [Genetic Function]
   804   C0332134:PDX [Qualitative Concept]
   804   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "to the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.7: adenoviral overexpression of DN-JNK preserved PDX-1 DNA binding activity in the face of oxidative stress, whereas wild type JNK overexpression decreased PDX-1 DNA binding activity. 

Phrase: "adenoviral overexpression of DN-JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: "PDX-1 DNA binding activity in the face of oxidative stress,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C2266866:Binding Activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "wild type JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "PDX-1 DNA binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.8: Furthermore, to examine whether suppression of the JNK pathway can protect -cells from the toxic effects of hyperglycemia, rat islets were infected with DN-JNK expressing adenovirus or control adenovirus and transplanted under renal capsules of streptozotocin-induced diabetic nude mice. 

Phrase: "Furthermore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "suppression of the JNK pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "can"

Phrase: "protect -"

Phrase: "cells from the toxic effects of hyperglycemia,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "rat islets"

Phrase: "were"

Phrase: "infected with DN-JNK expressing adenovirus"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   767   C0884118:Adenovirus type [Virus]
   744   C0001483:Adenovirus, NOS [Virus]
   744   C0001486:Adenovirus [Disease or Syndrome]
   744   C0205160:Negative [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0439663:Infected [Functional Concept]
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1513916:Negative [Finding]
   744   C1527180:Dominant [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C1705632:JNK [Gene or Genome]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "control adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001483:Adenovirus, NOS [Virus]
   861   C0001486:Adenovirus [Disease or Syndrome]
   861   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "transplanted under renal capsules of streptozotocin-induced diabetic nude mice."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   760   C0025932:Mice, Nude [Mammal]
   741   C0022671:Renal transplant [Therapeutic or Preventive Procedure]
   739   C0006935:Capsules [Biomedical or Dental Material]
   739   C0022646:Renal [Body Part, Organ, or Organ Component]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   739   C0040732:transplanted [Therapeutic or Preventive Procedure]
   739   C0205263:Induced [Functional Concept]
   739   C0241863:DIABETIC [Finding]
   739   C0332835:transplanted [Tissue]
   739   C0700106:Transplanted [Functional Concept]
   739   C1425014:NUDE [Gene or Genome]
   726   C0227616:Renal capsule [Body Part, Organ, or Organ Component]
   726   C1281091:Renal capsule [Body Part, Organ, or Organ Component]
   706 E C1325531:capsule [Cell Component]
   706 E C1704652:Capsule [Qualitative Concept]
   706 E C1706433:{Capsule} [Quantitative Concept]
Processing 00000000.tx.9: In mice receiving DN-JNK overexpressing islets, insulin gene expression in islet grafts was preserved, and hyperglycemia was ameliorated compared with control mice. 

Phrase: "In mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "DN-JNK overexpressing islets,"

Phrase: "insulin gene expression in islet grafts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   790   C1337112:Insulin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: ","

Phrase: "and"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "ameliorated"

Phrase: "compared with control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.10: In conclusion, activation of JNK is involved in the reduction of insulin gene expression by oxidative stress, and suppression of the JNK pathway protects -cells from oxidative stress.  

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "involved in the reduction of insulin gene expression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0017262:Gene Expression [Genetic Function]
   770   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C1314939:Involved [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "suppression of the JNK pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "protects -"

Phrase: "cells from oxidative stress."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Some of the -cell failure that is fundamental to diabetes appears to be because of the adverse effects of chronic hyperglycemia on -cells, a process called glucose toxicity, which leads to suppression of insulin gene transcription and glucose-stimulated insulin secretion (1-7). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Some of the -cell failure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0205392:Some [Quantitative Concept]
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3540770:Some [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "fundamental to diabetes"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be because of the adverse effects of chronic hyperglycemia on -cells,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   756   C0001688:adverse effects [Functional Concept]
   756   C0342300:Chronic hyperglycaemia [Pathologic Function]
   756   C0879626:Adverse effects [Pathologic Function]
   738   C0007634:Cells [Cell]
   738   C0020456:Hyperglycaemia [Disease or Syndrome]
   738   C0205191:chronic [Temporal Concept]
   738   C1280500:effects [Qualitative Concept]
   738   C2987476:Be [Conceptual Entity]
   738   C3282337:Cells [Cell]
   722 E C0559546:Adverse Effect [Finding]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "glucose toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "which"

Phrase: "leads to suppression of insulin gene transcription"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0040649:Gene Transcription [Genetic Function]
           Transcription
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: The reduction of expression or DNA binding activity of the pancreatic and duodenal homeobox factor-1 (PDX-1)1 (also known as IDX-1/STF-1/IPF1) (8-12) is often observed simultaneously with suppression of insulin gene transcription (3, 4, 7). 

Phrase: "The reduction of expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "DNA binding activity of the pancreatic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "duodenal homeobox factor-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: "(PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(also"

Phrase: "known as IDX-1/STF-1/IPF1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1826562:IDX-1 [Gene or Genome]
           STF-1
           IPF1
   774   C0171961:STF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205309:Known [Qualitative Concept]
   748   C0599939:STF [Amino Acid, Peptide, or Protein,Hormone,Immunologic Factor]

Phrase: ")"

Phrase: "(8-12"

Phrase: ")"

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "simultaneously with suppression of insulin gene transcription"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0040649:Gene Transcription [Genetic Function]
           Transcription
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0521115:simultaneously [Temporal Concept]
   748   C0728721:suppression [Mental Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.13: PDX-1, a member of the homeodomain family of transcription factors, plays an important role in pancreas development (13-16) and differentiation (17-20) and in maintaining normal -cell function by regulating the expression of multiple genes, including insulin, GLUT2, and glucokinase (21-24). 

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "a member of the homeodomain family of transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in pancreas development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(13-16"

Phrase: ")"

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(17-20"

Phrase: ")"

Phrase: "and in maintaining normal -cell function"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0007613:Cell Function [Cell Function]
   790   C0007634:Normal cell [Cell]
           Cell
   790   C1268443:Normal cell [Cell]
   753   C0031843:function [Physiologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1704653:Cell [Medical Device]
   753   C1705273:Function [Intellectual Product]
   753   C1948049:Cell [Spatial Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0024501:Maintain [Activity]

Phrase: "by"

Phrase: "regulating"

Phrase: "the expression of multiple genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "GLUT2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420172:GLUT2 [Gene or Genome]

Phrase: "and"

Phrase: "glucokinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "(21-24"

Phrase: ")."
Processing 00000000.tx.14: It has been postulated that oxidative stress (25) which is found in the diabetic state (26-28) is involved in the progression of -cell deterioration (29-35) as well as in the development of diabetic complications (27, 36-38). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "which"

Phrase: "is"

Phrase: "found in the diabetic state"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Found [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726 E C0243095:Find [Finding]

Phrase: "(26-28"

Phrase: ")"

Phrase: "is"

Phrase: "involved in the progression of -cell deterioration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007634:Cell [Cell]
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C0868945:Deterioration [Phenomenon or Process]
   748   C1269647:Cell [Cell]
   748   C1314939:Involved [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(29-35"

Phrase: ")"

Phrase: "as well as in the development of diabetic complications"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0342257:Diabetic Complications [Pathologic Function]
   742   C0009566:Complications [Pathologic Function]
   742   C0205170:Well [Qualitative Concept]
   742   C0241863:DIABETIC [Finding]
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1171258:complications [Pathologic Function]
   742   C1527148:Development [Functional Concept]
   742   C3146287:Well [Manufactured Object]
   708 E C2362589:Complication [Idea or Concept]

Phrase: "(27,"

Phrase: "36-38"

Phrase: ")."
Processing 00000000.tx.15: In fact, in the presence of diabetes, reactive oxygen species (ROS) are produced in islets (26) as well as in various tissues (27, 28) through several processes such as the non-enzymatic glycosylation reaction (37, 39, 40), the electron transport chain in mitochondria (27), and the hexosamine pathway (35). 

Phrase: "In fact,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "reactive oxygen species (ROS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "produced in islets"

Phrase: "(26"

Phrase: ")"

Phrase: "as well as in various tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0040300:Tissues [Tissue]
   753   C0205170:Well [Qualitative Concept]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C3146287:Well [Manufactured Object]
   719 E C1547928:Tissue [Intellectual Product]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "through several processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "such as the non-enzymatic glycosylation reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1511131:Enzymatic Reaction [Molecular Function]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "(37,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the electron transport chain in mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2244392:electron transport chain [Molecular Function]
   753   C0337112:Chain [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the hexosamine pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.16: Furthermore, it has been reported that levels of 8-hydroxy-2'-deoxyguanosine, a marker for oxidative stress, are increased in the blood of type 2diabetic patients (41, 42). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that levels of 8-hydroxy-2'-deoxyguanosine,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "a marker for oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "increased in the blood of type 2diabetic patients"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0005810:blood type [Classification]
   767   C1383165:Blood Type [Clinical Attribute]
   767   C3274467:Blood Type [Diagnostic Procedure]
   750   C1550335:Patient type [Classification]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205217:Increased [Quantitative Concept]
   744   C0229664:Blood [Body Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.17: Because expression levels of the antioxidant enzymes, superoxide dismutase, catalase, and glutathione peroxidase, are relatively low in islets as compared with other tissues (43), -cells can be expected to be vulnerable to oxidative stress. 

Phrase: "Because"

Phrase: "expression levels of the antioxidant enzymes,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C0014440:enzymes levels [Laboratory Procedure]
   783   C1287349:enzymes levels [Laboratory or Test Result]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "superoxide dismutase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "glutathione peroxidase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "are"

Phrase: "relatively low in islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "as"

Phrase: "compared with other tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040300:Tissues [Tissue]
   770   C1707455:Compared [Activity]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "(43"

Phrase: ")"

Phrase: ", -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "vulnerable to oxidative stress."
Processing 00000000.tx.18: Indeed, studies have shown that oxidative stress exerts deleterious effects upon -cells in the diabetic state, suppressing insulin gene transcription and glucose-stimulated insulin secretion, and even producing apoptosis (29-35). 

Phrase: "Indeed,"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "deleterious effects upon -cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in the diabetic state,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "and"

Phrase: "glucose-stimulated insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "even"

Phrase: "producing"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(29-35"

Phrase: ")."
Processing 00000000.tx.19: Expression and DNA binding activity of PDX-1 are also suppressed by oxidative stress (30, 32, 33, 35). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "DNA binding activity of PDX-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "also"

Phrase: "suppressed by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1260953:Suppressed [Functional Concept]

Phrase: "(30,"

Phrase: "32,"

Phrase: "33,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.20: Furthermore, some toxic effects of hyperglycemia on -cells in rodent models are reduced by antioxidant treatment (32-34). 

Phrase: "Furthermore,"

Phrase: "some toxic effects of hyperglycemia on -cells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   748   C1280500:effects [Qualitative Concept]
   748   C1407029:Toxic [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in rodent models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "reduced by antioxidant treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0003402:Antioxidant [Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(32-34"

Phrase: ")."
Processing 00000000.tx.21: Thus, it is likely that oxidative stress mediates some of the toxic effects of hyperglycemia. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "some of the toxic effects of hyperglycemia."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   748   C0205392:Some [Quantitative Concept]
   748   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   748   C1280500:effects [Qualitative Concept]
   748   C1407029:Toxic [Qualitative Concept]
   748   C3540770:Some [Intellectual Product]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.22: Several signal transduction pathways including c-Jun N-terminal kinase (JNK) (also known as stress-activated protein kinase) (44, 45), p38 mitogen-activated protein kinase (MAPK), and protein kinase C (PKC) are known to be activated by oxidative stress (25, 46) or high glucose (46-48) in several cell types. 

Phrase: "Several signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0086982:Signal Transduction Pathways [Molecular Function]
   875   C0037080:Signal Pathways [Molecular Function]
   861   C0037083:Signal Transduction [Cell Function]
   812   C1160185:transduction [Organism Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(JNK) (also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "known as stress-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0038435:Stress [Finding]
   753   C0205309:Known [Qualitative Concept]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "(44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "p38 mitogen-activated protein kinase (MAPK),"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "protein kinase C (PKC)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated by oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "(25,"

Phrase: "46"

Phrase: ")"

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(46-48"

Phrase: ")"

Phrase: "in several cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.23: However, it is not known which of these kinases is activated in pancreatic islets and involved in oxidative stress-mediated suppression of insulin gene transcription. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "which of these kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated in pancreatic islets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "involved in oxidative stress-mediated suppression of insulin gene transcription."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C0040649:Gene Transcription [Genetic Function]
           Transcription
   760   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C1337112:Insulin Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0038435:Stress [Finding]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0311404:Oxidative [Functional Concept]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1314939:Involved [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.24: In this study, we show that activation of JNK is involved in reduction of insulin gene expression by oxidative stress and that suppression of the JNK pathway can protect -cells from oxidative stress.  

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "involved in reduction of insulin gene expression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "that suppression of the JNK pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "can"

Phrase: "protect -"

Phrase: "cells from oxidative stress."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.25: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Isolation and Culture of Rat Pancreatic Islets-- Islets were isolated from pancreases of 200-250-g male Sprague-Dawley rats (Taconic Farms, Germantown, NY) with collagenase digestion. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Culture of Rat Pancreatic Islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Islets"

Phrase: "were"

Phrase: "isolated from pancreases of 200-250-g male Sprague-Dawley rats"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   775   C0034715:Rats, Sprague-Dawley [Mammal]
   756   C2699239:Sprague-Dawley [Mammal]
   738   C0024554:Male [Finding]
   738   C0034693:rats [Mammal]
   738   C0034721:Rats [Mammal]
   738   C0086582:male [Population Group]
   738   C0205409:Isolated [Functional Concept]
   738   C0439267:g% [Quantitative Concept]
   738   C1548221:Isolated [Idea or Concept]
   738   C1706180:Male [Qualitative Concept]
   738   C1706428:Male [Qualitative Concept]
   738   C1706429:Male [Organism Attribute]
   721   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   704   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   704 E C0370215:Isolate [Substance]
   704   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   704 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Taconic Farms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557759:farms [Geographic Area]

Phrase: "Germantown,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "with collagenase digestion."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.26: The common bile duct was cannulated and injected with 6ml of cold M199 medium containing 1.5mg/ml collagenase (Roche Molecular Biochemicals). 

Phrase: "The common bile duct"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0009437:Common Bile Duct [Body Part, Organ, or Organ Component]
   913   C1550229:Common Duct [Body Part, Organ, or Organ Component]
   901   C0005400:Bile duct [Body Part, Organ, or Organ Component]
   901   C1280889:Bile duct [Body Part, Organ, or Organ Component]
   901   C1711174:DUCT, BILE [Tissue]
   827   C0005388:Bile [Body Substance]
   827   C0205214:Common [Quantitative Concept]
   827   C0687028:Duct [Body Part, Organ, or Organ Component]
   827   C1267211:Duct [Body Part, Organ, or Organ Component]
   827   C1522138:Common [Functional Concept]
   827   C1550227:duct [Body Part, Organ, or Organ Component]
   827   C1705650:Duct [Medical Device]
   827   C3245511:common [Intellectual Product]
   755 E C1512083:Ductal [Qualitative Concept]

Phrase: "was"

Phrase: "cannulated"

Phrase: "and"

Phrase: "injected with 6ml of cold M199 medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0456913:Cold medium [Finding]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0009458:Medium [Intellectual Product]
   748   C0234192:Cold [Physiologic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]
   714   C1720154:Inject [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.5mg/ml collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.27: The islets were separated on a Histopaque 1077(Sigma) density gradient. 

Phrase: "The islets"

Phrase: "were"

Phrase: "separated on a Histopaque 1077"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086972:Separated [Finding]
   760   C0164836:histopaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "density gradient."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0178587:density [Quantitative Concept]
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.28: The washed islets were hand-picked individually under a dissecting microscope to ensure a pure islet preparation and cultured in RPMI 1640medium (11mM glucose, supplemented with 10% fetal calf serum, 100units/ml penicillin, and 0.1mg/ml streptomycin sulfate) in a humidified atmosphere of 5% CO2 at 37C. 

Phrase: "The washed islets"

Phrase: "were"

Phrase: "hand-picked"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   861   C1707391:Picked [Activity]
   827 E C1826583:PICK [Gene or Genome]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "individually under a dissecting microscope to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0181839:Microscope [Medical Device]
   753   C0205239:Dissecting [Functional Concept]
   753   C1706379:Microscope [Medical Device]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "a pure islet preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "cultured in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(11mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "supplemented with 10% fetal calf serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "0.1mg/ml streptomycin sulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0038426:Streptomycin Sulfate [Antibiotic,Carbohydrate]
   804   C0038425:Streptomycin [Antibiotic,Carbohydrate]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "of 5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "at 37C."
Processing 00000000.tx.29: All animal procedures were approved by the Animal Care Committee of the Joslin Diabetes Center. 

Phrase: "All animal procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "approved by the Animal Care Committee of the Joslin Diabetes Center."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C0003045:Committee, Animal Care [Professional or Occupational Group]
   756   C0178478:animal care [Occupation or Discipline]
   738   C0003062:Animal [Animal]
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0205099:Center [Spatial Concept]
   738   C0205540:Approved [Qualitative Concept]
   738   C1947933:Care [Activity]
   738   C2699414:Committee [Group]
Processing 00000000.tx.30: Preparation of Recombinant Adenoviruses Expressing Wild Type (WT) and Dominant-negative Type (DN) JNK-- Recombinant adenoviruses expressing WT- and DN-JNK (44, 45) were prepared using the AdEasy system (kindly provided by Dr. Bert Vogelstein, The Johns Hopkins Oncology Center) (49). 

Phrase: "Preparation of Recombinant Adenoviruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "Expressing"

Phrase: "Wild Type (WT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Dominant-negative Type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "(DN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "JNK-- Recombinant adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0001483:Adenoviruses [Virus]
   827   C1514798:recombinant [Organism]
   793 E C0001486:Adenovirus [Disease or Syndrome]
   793 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "WT-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "DN-JNK (44,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   840   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   804   C0205160:Negative [Qualitative Concept]
   804   C0332307:Type [Qualitative Concept]
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1513916:Negative [Finding]
   804   C1527180:Dominant [Functional Concept]
   804   C1547052:*Type [Quantitative Concept]
   804   C1705632:JNK [Gene or Genome]
   804   C2825415:Negative [Conceptual Entity]
   804   C2825491:Negative [Qualitative Concept]

Phrase: "45"

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AdEasy system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(kindly"

Phrase: "provided by Dr. Bert Vogelstein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "The Johns Hopkins Oncology Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.31: It should be noted that this DN-JNK is a kinase-dead mutant (the ATP-binding site is mutated); 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "this DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "a kinase-dead mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "the ATP-binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   901   C1148923:ATP binding [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.32: this DN-JNK can be phosphorylated but cannot phosphorylate c-Jun. 

Phrase: "this DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "but"

Phrase: "cannot"

Phrase: "phosphorylate"

Phrase: "c-Jun."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.33: In brief, the encoding region of WT- and DN-JNK (K55R) was cloned into the XbaI-EcoRV site of a shuttle vector pAdTrack-CMV. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "the encoding region of WT-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "DN-JNK (K55R"

Phrase: ")"

Phrase: "was"

Phrase: "cloned into the XbaI-EcoRV site"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0009013:cloned [Cell]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "of a shuttle vector pAdTrack-CMV."
Processing 00000000.tx.34: To produce homologous recombination, 1.0g of linearized plasmid containing WT- or DN-JNK and 0.1g of the adenoviral backbone plasmid, pAdEasy-1, were introduced into electrocompetent Escherichia coli BJ5183 cells with electroporation (2,500V, 200ohms). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "homologous recombination,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0599773:Homologous Recombination [Genetic Function]
  1000   C2984295:Homologous recombination [Functional Concept]
   861   C0034865:Recombination [Genetic Function]
   861   C1334043:Homologous [Gene or Genome]

Phrase: "1.0g of linearized plasmid"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "WT-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "0.1g of the adenoviral backbone plasmid,"

Phrase: "pAdEasy-1,"

Phrase: "were"

Phrase: "introduced into electrocompetent Escherichia coli BJ5183 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0014834:Escherichia coli [Bacterium]
   748   C0007634:Cells [Cell]
   748   C0014833:Escherichia [Bacterium]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714   C1292748:introduce [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "with electroporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206691:Electroporation [Laboratory Procedure,Research Activity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "500V,"

Phrase: "200ohms"

Phrase: ")."
Processing 00000000.tx.35: Then the resultant plasmids were re-transformed into E.coli XL-Gold Ultracompetent Cells (Stratagene, La Jolla, CA). 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the resultant plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "re-"

Phrase: "transformed into E.coli XL-Gold Ultracompetent Cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0014834:E coli [Bacterium]
   744   C0007634:Cells [Cell]
   744   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1304897:Gold [Functional Concept]
   744   C1510411:Transformed [Pathologic Function]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.36: The plasmids were linearized with PacI and then transfected into the adenovirus packaging cell line 293using LipofectAMINE (Invitrogen, Carlsbad, CA). 

Phrase: "The plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "linearized with PacI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1165245:paci [Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transfected into the adenovirus packaging cell line 293using LipofectAMINE"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   764   C0007600:Cell Line [Cell]
   742   C0001483:Adenovirus, NOS [Virus]
   742   C0001486:Adenovirus [Disease or Syndrome]
   742   C0007634:Cell [Cell]
   742   C0013194:Packaging [Medical Device]
   742   C0030176:Packaging [Human-caused Phenomenon or Process]
   742   C0205132:Line [Spatial Concept]
   742   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
   742   C1269647:Cell [Cell]
   742   C1550648:Line [Substance]
   742   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2828395:Packaging [Activity]
   708 E C2700580:Package [Manufactured Object]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)."
Processing 00000000.tx.37: Ten days after transfection, cell lysate was obtained from the 293cells. 

Phrase: "Ten days after transfection,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   816   C1710369:TEN-DAY [Intellectual Product]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "obtained from the 293cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.38: The cell lysate was added to 293cells again, and when most of the cells were killed by the adenovirus infection and detached, the cell lysate was obtained again (this process was repeated three times). 

Phrase: "The cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "added to 293cells again,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "when"

Phrase: "most of the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205393:Most [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "killed by the adenovirus infection"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0001486:Adenovirus infection [Disease or Syndrome]
           Adenovirus
   760   C0001483:Adenovirus, NOS [Virus]
   760   C0009450:Infection, NOS [Disease or Syndrome]
   760   C0162388:killed [Social Behavior]
   760   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "detached,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0687118:Detached [Functional Concept]
  1000   C1561504:detached [Idea or Concept]
   928 E C0541879:detachment [Mental Process]
   928 E C0595950:Detachment [Pathologic Function]

Phrase: "the cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "again"

Phrase: "("

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.39: Control adenovirus expressing green fluorescent protein (Ad-GFP) was prepared in the same manner. 

Phrase: "Control adenovirus expressing green fluorescent protein (Ad-GFP)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   876   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0001483:Adenovirus, NOS [Virus]
   799   C0001486:Adenovirus [Disease or Syndrome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243148:control [Qualitative Concept]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0332583:Green [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "prepared in the same manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445247:Same [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.40: To determine viral titers, confluent 293cells were infected with a 1:10,000 dilution of the final lysate containing Ad-WT-JNK or Ad-DN-JNK (with GFP). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "viral titers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475208:Titer [Quantitative Concept]

Phrase: "confluent 293cells"

Phrase: "were"

Phrase: "infected with a 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]

Phrase: ":"

Phrase: "10,000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: "of the final lysate containing Ad-WT-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1150587:JNK [Molecular Function]
   795   C1367731:JNK [Gene or Genome]
   795   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-DN-JNK (with GFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1705632:JNK [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.41: After 18h of incubation, the effective titer was determined by the following formula: 107the average number of GFP-positive cells per field (100 magnification), which was considered equivalent to plaque-forming units (pfu)/ml. 

Phrase: "After 18h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442448:18H [Temporal Concept]

Phrase: "of incubation,"

Phrase: "the effective titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475208:Titer [Quantitative Concept]

Phrase: "was"

Phrase: "determined by the following formula"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0489829:Formula [Intellectual Product]
   760   C1705501:Formula [Intellectual Product]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "107the average number of GFP-positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "per field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
  1000   C1521738:Field [Conceptual Entity]
  1000   C2346620:Field [Conceptual Entity]
  1000   C2349184:Field [Conceptual Entity]
  1000   C3539073:FIELD [Spatial Concept]

Phrase: "(100 magnification"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "equivalent to plaque-forming units (pfu)/ml."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0439185:equivalent - unit [Quantitative Concept]
           equivalent
   753   C0205163:Equivalent [Qualitative Concept]
Processing 00000000.tx.42: This number was considered to be proportional to the number of infective particles in the original lysates. 

Phrase: "This number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "proportional to the number of infective particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]

Phrase: "in the original lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]
Processing 00000000.tx.43: Isolated rat islets (~300 islets) were infected with Ad-WT-JNK, Ad-DN-JNK, or Ad-GFP, using a 1-h exposure to the adenovirus (1108 pfu/ml). 

Phrase: "Isolated rat islets"

Phrase: "(~300 islets"

Phrase: ")"

Phrase: "were"

Phrase: "infected with Ad-WT-JNK,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1705632:JNK [Gene or Genome]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 1-h exposure to the adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(1108 pfu/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C2945590:unit/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   717   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.44: One hour after infection the islets were cultured in 3ml of RPMI medium in 6-cm bacteriologic Petri dishes. 

Phrase: "One hour after infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "the islets"

Phrase: "were"

Phrase: "cultured in 3ml of RPMI medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "in 6-cm bacteriologic Petri dishes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1322960:Petri dish [Medical Device]
   771   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.45: RNA Extraction and cDNA Synthesis-- Total RNA was extracted from islets using Trizol (Invitrogen). 

Phrase: "RNA Extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "cDNA Synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "--"

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Trizol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.46: After quantification by spectrophotometry, 500ng of RNA was heated at 85C for 3min and then reverse-transcribed into cDNA in a 25-l solution containing 200units of Superscript II RNase H reverse transcriptase (Invitrogen), 50ng of random hexamers (Invitrogen), 160M dNTP, and 10mM dithiothreitol. 

Phrase: "After quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "by spectrophotometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037805:Spectrophotometry [Laboratory Procedure]

Phrase: "500ng of RNA"

Phrase: "was"

Phrase: "heated at 85C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 3min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "-"

Phrase: "transcribed into cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in a 25-l solution containing 200units"

Phrase: "of Superscript II RNase H reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1555029:Reverse [Idea or Concept]
   799   C2257077:transcriptase [Genetic Function]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "50ng of random hexamers"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "160M dNTP,"

Phrase: "and"

Phrase: "10mM dithiothreitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.47: The reactions took place for 10min at 25C, 60min at 42C, and 10min at 95C. 

Phrase: "The reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "place for 10min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442504:Place [Spatial Concept]
   790   C1704765:Place [Functional Concept]
   790   C1882509:Place [Activity]
   790   C3496241:place [Disease or Syndrome]

Phrase: "at 25C,"

Phrase: "60min at 42C,"

Phrase: "and"

Phrase: "10min at 95C."
Processing 00000000.tx.48: The final cDNA reaction products were then diluted with 50l of H2O to a concentration corresponding to 20ng of starting RNA (20ng RNA equivalents) per 3l. 

Phrase: "The final cDNA reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "diluted with 50l of H2O"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "to a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "corresponding to 20ng of starting RNA (20ng RNA equivalents"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0439185:Equivalents [Quantitative Concept]
   708 E C0205163:Equivalent [Qualitative Concept]
   708   C0439659:Start [Temporal Concept]

Phrase: ")"

Phrase: "per 3l."
Processing 00000000.tx.49: Semiquantitative Radioactive PCR-- Polymerization reactions were performed with a PerkinElmer Life Sciences 9700Thermocycler using a 50-l reaction volume containing 3l of cDNA (20ng of RNA equivalents), 5units of AmpliTaq Gold DNA polymerase (PerkinElmer Life Sciences), 1.5mM MgCl2, 160M cold dNTPs, 2.5Ci of [-32P]dCTP, and 10pmol of appropriate oligonucleotide primers. 

Phrase: "Semiquantitative Radioactive PCR-- Polymerization reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0443286:Reaction [Functional Concept]
   771   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed with a PerkinElmer Life Sciences 9700Thermocycler"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0005526:Life Sciences [Occupation or Discipline]
   748   C0036397:Sciences [Occupation or Discipline]
   748   C0376558:Life [Idea or Concept]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 50-l reaction volume containing 3l of cDNA (20ng"

Phrase: "of RNA equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439185:Equivalents [Quantitative Concept]
   827 E C0205163:Equivalent [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5units of AmpliTaq Gold DNA polymerase"

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: ","

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "160M cold dNTPs,"

Phrase: "2.5Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]dCTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "10pmol of appropriate oligonucleotide primers."
Processing 00000000.tx.50: The oligonucleotide primers were as follows: insulin (forward), TCT TCT ACA CAC CCA TGT CCC, and insulin (reverse) GGT GCA GCA CTG ATC CAC; 

Phrase: "The oligonucleotide primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206415:Oligonucleotide Primers [Nucleic Acid, Nucleoside, or Nucleotide]
           Primer

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "TCT TCT ACA CAC CCA TGT CCC,"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: "GGT GCA GCA CTG ATC CAC"

Phrase: ";"
Processing 00000000.tx.51: cyclophilin (forward), AAC CCC ACC GTG TTC TTC, and cyclophilin (reverse), TGC CTT CTT TCA CCT TCC C; 

Phrase: "cyclophilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136073:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0917877:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1325303:cyclophilin [Molecular Function]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "AAC CCC ACC GTG TTC TTC,"

Phrase: "and"

Phrase: "cyclophilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136073:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0917877:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1325303:cyclophilin [Molecular Function]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "TGC CTT CTT TCA CCT TCC C"

Phrase: ";"
Processing 00000000.tx.52: -tubulin (forward), CTC GCA TCC ACT TCC CTC, and -tubulin (reverse), ATG CCC TCA CCC ACG TAC; 

Phrase: "-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "CTC GCA TCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0077072:TCC [Organic Chemical,Pharmacologic Substance]
   827   C1167383:TCC [Cell Component]
   827   C1861305:TCC [Disease or Syndrome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "TCC CTC,"

Phrase: "and -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "ATG CCC TCA CCC ACG TAC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1883257:TAC [Therapeutic or Preventive Procedure]
   799   C2962221:TAC [Pharmacologic Substance]
   799   C2986848:TAC [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.53: glucagon (forward), ACC TAG ACT CCC GCC GTG, and glucagon (reverse), ATG TCT GCG CCC AAG TTC; 

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "ACC TAG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "CCC GCC GTG,"

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "ATG TCT GCG CCC AAG TTC"

Phrase: ";"
Processing 00000000.tx.54: JNK (forward), ATC CAG CAG AAG CAA GCG, and JNK (reverse), GCC AGA CCG AAG TCA AGA ATC. 

Phrase: "JNK ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "ATC CAG CAG AAG CAA GCG,"

Phrase: "and"

Phrase: "JNK ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "GCC AGA CCG AAG TCA AGA ATC."
Processing 00000000.tx.55: The primers for 18S rRNA were purchased from Ambion (Austin, TX). 

Phrase: "The primers for 18S rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Ambion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "TX"

Phrase: ")."
Processing 00000000.tx.56: The thermal cycle profile employed a 10-min denaturing step at 94C followed by the number of amplification cycles (1min of denaturation at 94C, 1min of annealing at 55C, and 1min of extension at 72C) and an extension step of 10min at 72C. 

Phrase: "The thermal cycle profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a 10-min denaturing step at 94C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "followed by the number of amplification cycles"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   714   C1511572:Cycle [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(1min of denaturation"

Phrase: "at 94C,"

Phrase: "1min of annealing"

Phrase: "at 55C,"

Phrase: "and"

Phrase: "1min of extension"

Phrase: "at 72C"

Phrase: ")"

Phrase: "and"

Phrase: "an extension step of 10min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "at 72C."
Processing 00000000.tx.57: The amplimers were separated on a 6% polyacrylamide gel. 

Phrase: "The amplimers"

Phrase: "were"

Phrase: "separated on a 6% polyacrylamide gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]
Processing 00000000.tx.58: The amount of [-32P]dCTP incorporated into each amplimer was measured with a PhosphorImager and quantified with the ImageQuant software (Amersham Biosciences). 

Phrase: "The amount of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "]dCTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "incorporated into each amplimer"

Phrase: "was"

Phrase: "measured with a PhosphorImager"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "quantified with the ImageQuant software"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037585:Software [Intellectual Product,Manufactured Object]
   726   C1709793:Quantify [Quantitative Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.59: The steps taken to validate the measurements of mRNA levels by semiquantitative-radioactive multiplex PCR have been reported previously (7). 

Phrase: "The steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261552:steps [Conceptual Entity]
   966 E C1704379:Step [Functional Concept]
   966 E C1705117:Step [Quantitative Concept]
   966 E C2825408:Step [Manufactured Object]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "the measurements of mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:measurements [Functional Concept]

Phrase: "by semiquantitative-radioactive multiplex PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3179032:Multiplex PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.60: Gel Mobility Shift Assay-- Cells were treated with 1ml of hypotonic buffer (20mM HEPES, pH 7.9,20mM NaF, 1mM EDTA, 1mM EGTA, 1mM Na4P2O7, 1mM Na3VO4, 1mM dithiothreitol); 

Phrase: "Gel Mobility Shift Assay"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0596608:gel mobility shift assay [Diagnostic Procedure]
   923   C0949632:Gel Shift Assay [Laboratory Procedure]
           Mobility Shift Assay
   812   C0005507:Assay [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0243073:assay [Qualitative Concept]
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C1382104:Gel [Substance]
   812   C1510438:Assay [Laboratory Procedure]
   812   C2347509:Shift [Phenomenon or Process]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 1ml of hypotonic buffer"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0241938:Hypotonic [Pathologic Function]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(20mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM Na4P2O7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0663811:Na4P2O7 [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "1mM Na3VO4,"

Phrase: "1mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.61: then 50l of high salt buffer (420mM NaCl and 20% glycerol in hypotonic buffer) was added to the pellet, followed by 1h of incubation at 4C. 

Phrase: "then 50l of high salt buffer"

Phrase: "(420mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "20% glycerol in hypotonic buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "added to the pellet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0441436:Pellet [Manufactured Object]
   770   C0993610:Pellet [Biomedical or Dental Material]
   770   C1524062:Added [Functional Concept]
   770   C1998480:Pellet [Quantitative Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "followed by 1h of incubation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1442450:1H [Temporal Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.62: The supernatants were used as nuclear extracts. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used as nuclear extracts."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   799   C1518434:Nuclear Extract [Biomedical or Dental Material]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
   737   C2828366:Extract [Substance]
Processing 00000000.tx.63: Two micrograms of nuclear extract were incubated with 2g of poly(dI-dC), 10mM HEPES, pH 7.8,0.1mM EDTA, 75mM KCl, 2.5mM MgCl2, 1mM dithiothreitol, 3% Ficoll at room temperature. 

Phrase: "Two micrograms of nuclear extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 2g of poly(dI-dC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0071406:poly dC [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0747726:POLY [Conceptual Entity]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C3538902:DI [Gene or Genome]
   748   C3541881:DI [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "10mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "75mM KCl,"

Phrase: "2.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "3% Ficoll at room temperature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016071:Ficoll [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.64: The binding reaction was initiated by adding 32P-labeled double-stranded oligonucleotide probes. 

Phrase: "The binding reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "initiated by adding 32P-labeled double-stranded oligonucleotide probes."
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   764   C0028952:Oligonucleotide Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   745   C0441087:Double probe [Medical Device]
   742   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0182400:Probes [Medical Device]
   742   C0205173:Double [Functional Concept]
   742   C1553631:32p [Medical Device]
   742   C1705764:Double [Activity]
   742   C1705765:Double [Qualitative Concept]
   742   C1708632:Labeled [Qualitative Concept]
   729   C1979882:Double strand [Qualitative Concept]
   708 E C0181496:Label [Manufactured Object]
   708   C1548602:Initiate [Idea or Concept]
   708 E C1704681:Probe [Gene or Genome]
   708   C1704686:Initiate [Functional Concept]
   708   C1883712:Add [Functional Concept]
   708 E C2347609:Probe [Chemical Viewed Functionally]
   708 E C2827499:Label [Governmental or Regulatory Activity]
   708 E C3536729:Probe [Manufactured Object]
Processing 00000000.tx.65: A double-stranded oligonucleotide reproducing the rat insulin gene II PDX-1-binding region and surrounding sequences (ACG TCC TCT TAA GAC TCT AAT TAC CCT ACG T) (Sigma) was used as a binding probe. 

Phrase: "A double-stranded oligonucleotide reproducing"

Phrase: "the rat insulin gene II PDX-1-binding region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   721 E C0205276:Regional [Spatial Concept]
   721 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "surrounding sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(ACG TCC TCT TAA GAC TCT AAT TAC CCT ACG T) (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used as a binding probe."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0182400:Probe [Medical Device]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.66: The sequences of the mutated type competitor were as follows, ACG TCC TCT TAA GAC TCG CCG TAC CCT ACG T.In some of the binding assays, anti-PDX-1 antiserum (24) was added to the reaction mixture 1h before addition of the DNA probes. 

Phrase: "The sequences of the mutated type competitor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ","

Phrase: "ACG TCC TCT TAA GAC TCG CCG TAC CCT ACG"

Phrase: "T.In some of the binding assays,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2603360:T' [Clinical Attribute]

Phrase: "anti-PDX-1 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: "was"

Phrase: "added to the reaction mixture 1h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0439962:Mixture [Substance]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1442450:1H [Temporal Concept]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of the DNA probes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0012893:DNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]
Processing 00000000.tx.67: After the binding reactions, samples were analyzed by separation on a 6% polyacrylamide gel in 1 TBE buffer (45mM Tris-HCl, 45mM boric acid, 1mM EDTA), followed by autoradiography. 

Phrase: "After the binding reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by separation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C0936012:Analyzed [Research Activity]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "on a 6% polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: "in 1 TBE buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0146923:TBE buffer [Organic Chemical]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(45mM Tris-HCl,"

Phrase: "45mM boric acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0006020:boric acid [Inorganic Chemical,Pharmacologic Substance]
           boric
   901   C1161318:boric acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "1mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "followed by autoradiography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0004400:Autoradiography [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.68: Cell Viability Assays-- Isolated rat islets (~200 islets) were exposed to 0-250 M H2O2 and incubated for 15min with fluorescein diacetate (10g/ml) (Sigma) and propidium iodide (0.5g/ml) (Amersham Biosciences) in 3ml of phosphate-buffered saline. 

Phrase: "Cell Viability Assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0007620:Cell Viability [Cell Function]

Phrase: "--"

Phrase: "Isolated rat islets"

Phrase: "(~200 islets"

Phrase: ")"

Phrase: "were"

Phrase: "exposed to 0-250 M H2O2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with fluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0046771:fluorescein diacetate [Organic Chemical]
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "(10g/ml) (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(0.5g/ml) (Amersham Biosciences"

Phrase: ")"

Phrase: "in 3ml"

Phrase: "of phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.69: Fluorescein diacetate enters cells and fluoresces green in viable cells; 

Phrase: "Fluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0046771:fluorescein diacetate [Organic Chemical]
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "green in viable cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.70: propidium iodide enters only dead or dying cells, binds to nucleic acids, and fluoresces red. 

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "only dead"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011065:Dead [Organism Function]

Phrase: "or"

Phrase: "dying cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "binds to nucleic acids,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0001128:Acids [Chemical]
   770   C0007610:Nucleic [Cell Component]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "red."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.71: The islets were then washed in phosphate-buffered saline and images acquired with a Magnafire camera on an Olympus fluorescent microscope. 

Phrase: "The islets"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed in phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "acquired with a Magnafire camera"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0179533:Camera [Medical Device]
   760   C0439661:Acquired [Temporal Concept]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "on an Olympus fluorescent microscope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]
Processing 00000000.tx.72: Western Blotting-- Cells were treated with lysis buffer (20mM Tris-HCl, pH 7.5,150mM NaCl, 1% Nonidet P-40); 

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with lysis buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1522326:Treated [Functional Concept]
   770   C1536403:lysis [Cell Function]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(20mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.73: then supernatants were collected. 

Phrase: "then supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.74: Ten micrograms of cell extracts were fractionated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Immun-BlotTM PVDF Membrane, Bio-Rad) using transfer buffer containing 20% methanol, 25mM Tris base, and 192mM glycine (300mA, 2h). 

Phrase: "Ten micrograms of cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "fractionated by 10% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "transferred to a polyvinylidene difluoride membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(Immun-BlotTM PVDF Membrane,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "Bio-Rad)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transfer buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20% methanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "25mM Tris base,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0041175:Tris-base [Organic Chemical,Pharmacologic Substance]
   827   C0002055:base [Inorganic Chemical]
   827   C0178499:Base [Chemical Viewed Functionally]
   827   C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
   743 E C0016617:Foundation [Organization]
   743 E C1626935:Bases [Quantitative Concept]

Phrase: "and"

Phrase: "192mM glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "(300mA,"

Phrase: "2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.75: After blocking the membranes at room temperature for 1h in 50mM Tris-HCl, 150mM NaCl, 0.1% Tween 20(TBS-T) with 5% nonfat dry milk, the membranes were incubated at 4C overnight in TBS-T with 5% nonfat dry milk containing a 1:1000 dilution of rabbit antibody for JNK, phosphorylated JNK, p38 MAPK, phosphorylated p38 MAPK, c-Jun, or phosphorylated c-Jun (Santa Cruz Biotechnology) and washed three times in TBS-T. 

Phrase: "After"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the membranes at room temperature"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "in 50mM Tris-HCl,"

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(TBS-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "T) with 5% nonfat dry milk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2603360:T' [Clinical Attribute]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated at 4C overnight"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439583:Overnight [Temporal Concept]
   770   C0450376:4c [Intellectual Product]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in TBS-T"

Phrase: "with 5% nonfat dry milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 1"

Phrase: ":"

Phrase: "1000 dilution of rabbit antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "for JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "phosphorylated JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "phosphorylated p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   947   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   926 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "c-Jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "phosphorylated c-Jun (Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "washed three times in TBS-T."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.76: The membranes were then incubated for 1h at room temperature in TBS-T with 5% nonfat dry milk containing a 1:1,000 dilution of anti-rabbit IgG antibody (Bio-Rad) coupled to horseradish peroxidase, followed by washing with TBS-T. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in TBS-T"

Phrase: "with 5% nonfat dry milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 1"

Phrase: ":"

Phrase: "1,000 dilution of anti-rabbit IgG antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079240:Dilution [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]

Phrase: "(Bio-Rad)"

Phrase: "coupled to horseradish peroxidase,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "followed by washing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0441648:Washing [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with TBS-T."
Processing 00000000.tx.77: Immunoreactive bands were made visible by incubation with LumiGLO (Cell Signaling, Beverly, MA) and exposed to x-ray film (Eastman Kodak). 

Phrase: "Immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "visible by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205379:Visible [Qualitative Concept]

Phrase: "with LumiGLO"

Phrase: "(Cell Signaling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Cell Signaling [Cell Function]
           Signaling
   861   C3537152:signaling [Biologic Function]

Phrase: "Beverly,"

Phrase: "MA)"

Phrase: "and"

Phrase: "exposed to x-ray film"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0043303:X-Ray Film [Medical Device]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
   760   C2314876:ray [Fish]

Phrase: "(Eastman Kodak"

Phrase: ")."
Processing 00000000.tx.78: Assay for PKC Activity-- Total PKC enzyme activity was determined using SignaTECT protein kinase C assay system (Promega, Madison, WI) using the conditions recommended by the manufacturer. 

Phrase: "Assay for PKC Activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0201578:Protein kinase C activity assay [Laboratory Procedure]
   814   C0919677:Protein C, assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   716   C1150572:protein kinase C activity [Molecular Function]

Phrase: "--"

Phrase: "Total PKC enzyme activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C1150572:protein kinase C activity [Molecular Function]
   885   C1150527:protein kinase activity [Molecular Function]
   879   C3642159:Protein C Activity [Laboratory Procedure]
   876   C1537044:protein activity [Molecular Function]
   867 E C2261495:protein phosphokinase activity [Molecular Function]
   858   C1150423:kinase activity [Molecular Function]
   827   C0243102:enzyme activity [Molecular Function]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SignaTECT protein kinase C assay system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]
   700   C0919677:protein c assay [Laboratory Procedure]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "recommended by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034866:Recommended [Idea or Concept]
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.79: In brief, cell lysates from islets were incubated with [-32P]ATP and PKC-biotinylated protein peptide substrate buffer at 30C for 5min and then spotted on SAM biotin capture membrane (Promega). 

Phrase: "In brief, cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "from islets"

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "and"

Phrase: "PKC-biotinylated protein peptide substrate buffer at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 5min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "spotted on SAM biotin capture membrane"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0025255:Membrane [Tissue]
   753   C0036002:SAM [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0279268:SAM [Therapeutic or Preventive Procedure]
   753   C0596901:Membrane [Cell Component]
   753   C1563296:SAM [Pathologic Function]
   753   C1706182:Membrane [Manufactured Object]
   753   C2700256:Biotin [Laboratory Procedure]
   719   C0329155:Spot [Fish]
   719   C1427618:SPOT [Gene or Genome]
   719   C1705203:Spot [Conceptual Entity]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.80: After washing with 2M NaCl and 2M NaCl in 1% H3PO4, PKC activity was examined with a scintillation counter. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with 2M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "2M NaCl in 1% H3PO4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "PKC activity"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1150572:protein kinase C activity [Molecular Function]
   923   C1150527:protein kinase activity [Molecular Function]
   923   C3642159:Protein C Activity [Laboratory Procedure]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   902   C1537044:protein activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "examined with a scintillation counter."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0036405:Scintillation Counter [Medical Device]
   806   C1710025:Scintillation Counter [Manufactured Object]
   760   C0332128:Examined [Finding]
   760   C0677601:Counter [Manufactured Object]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1705206:Counter [Medical Device]
Processing 00000000.tx.81: Evaluation of Glucose-stimulated Insulin Secretion-- Glucose-stimulated insulin secretion was determined by static incubation. 

Phrase: "Evaluation of Glucose-stimulated Insulin Secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "--"

Phrase: "Glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by static incubation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441463:Static [Qualitative Concept]
Processing 00000000.tx.82: Isolated rat islets (50islets) were preincubated for 30min in 2ml of HEPES-balanced Krebs-Ringer bicarbonate buffer and then incubated for 60min in the same buffer supplemented with 0.5% bovine serum albumin and either 2.8or 16.7mM glucose in 6-well bacteriologic Petri dishes. 

Phrase: "Isolated rat islets"

Phrase: "(50islets"

Phrase: ")"

Phrase: "were"

Phrase: "preincubated for 30min"

Phrase: "in 2ml"

Phrase: "of HEPES-balanced Krebs-Ringer bicarbonate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0973231:Bicarbonate [Inorganic Chemical]
   799   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   799   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 60min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 0.5% bovine serum albumin"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   778   C0444499:0/5 [Quantitative Concept]
   778   C0728877:serum albumin [Laboratory or Test Result]
   774 E C0523465:Albumin - serum [Laboratory Procedure]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007452:Bovine [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "either 2.8or 16.7mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in 6-well bacteriologic Petri dishes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1322960:Petri dish [Medical Device]
   771   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.83: The insulin secreted into the medium was determined with a radioimmunoassay kit (Linco Research, St Charles, MO), using rat insulin as the standard. 

Phrase: "The insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secreted into the medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1327616:Secreted [Cell Function]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "determined with a radioimmunoassay kit (Linco Research,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0034580:Radioimmunoassay [Laboratory Procedure]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: "St Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat insulin as the standard."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.84: Islet Transplantation-- Male immune-deficient athymic Swiss nude mice (8weeks old) (Taconic Farms) were made diabetic by intraperitoneal injection of streptozotocin (STZ) (250mg/kg) (Sigma), freshly dissolved in citrate buffer (pH 4.5), and used as graft recipients. 

Phrase: "Islet Transplantation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079646:Transplantation, Islet [Therapeutic or Preventive Procedure]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]

Phrase: "--"

Phrase: "Male immune-deficient athymic Swiss nude mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C0025932:Mice, Athymic [Mammal]
           Athymic Nude Mouse
           Mice, Nude
   829   C0162416:Swiss Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   795   C1425014:NUDE [Gene or Genome]

Phrase: "(8weeks old) (Taconic Farms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0557759:farms [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "diabetic by intraperitoneal injection of streptozotocin (STZ)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0241863:DIABETIC [Finding]

Phrase: "(250mg/kg) (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "freshly"

Phrase: "dissolved in citrate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3256468:citrate buffer [Pharmacologic Substance]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0008857:Citrate [Organic Chemical]
   770   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   737   C1549535:Dissolve [Functional Concept]

Phrase: "(pH 4.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "used as graft recipients."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   819   C0449871:Graft used [Therapeutic or Preventive Procedure]
   770   C0181074:{Graft} [Biomedical or Dental Material]
   770   C0332835:Graft [Tissue]
   770   C1273517:used [Finding]
   770   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1709854:Recipient [Human]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.85: Islets isolated from Sprague-Dawley rats were infected with Ad-DN-JNK or Ad-GFP (1108 pfu/ml), using a 1-h exposure to the adenovirus. 

Phrase: "Islets"

Phrase: "isolated from Sprague-Dawley rats"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   862   C0034715:Rats, Sprague-Dawley [Mammal]
   806   C2699239:Sprague-Dawley [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "infected with Ad-DN-JNK"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "Ad-GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(1108 pfu/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C2945590:unit/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   717   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 1-h exposure to the adenovirus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.86: One hour after infection the islets were cultured for 2days in 3ml of RPMI medium in 6-cm bacteriologic Petri dishes, and then 500islets were transplanted under kidney capsules of Swiss nude mice. 

Phrase: "One hour after infection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "the islets"

Phrase: "were"

Phrase: "cultured for 2days"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in 3ml"

Phrase: "of RPMI medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "in 6-cm bacteriologic Petri dishes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1322960:Petri dish [Medical Device]
   771   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "then 500islets"

Phrase: "were"

Phrase: "transplanted under kidney capsules of Swiss nude mice."
Meta Candidates (Total=28; Excluded=6; Pruned=0; Remaining=22)
   782   C0227616:Capsule of kidney [Body Part, Organ, or Organ Component]
           capsule kidney
   782   C1281091:Capsule of kidney [Body Part, Organ, or Organ Component]
       E   Renal capsule
   778   C0022671:Transplant of kidney [Therapeutic or Preventive Procedure]
       E   Kidney transplant
   770   C0025932:Mice, Nude [Mammal]
   767   C0162416:Swiss Mice [Mammal]
   767   C0677491:kidney transplanted [Finding]
   767   C1261317:Transplanted kidney [Body Part, Organ, or Organ Component]
   750 E C0040745:Transplant kidney [Body Part, Organ, or Organ Component]
   750   C1517673:Mouse Kidney [Tissue]
   744   C0006935:Capsules [Biomedical or Dental Material]
   744   C0022646:Kidney [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0040732:transplanted [Therapeutic or Preventive Procedure]
   744   C0227665:kidney [Body Part, Organ, or Organ Component]
   744   C0241315:Swiss [Population Group]
   744   C0332835:transplanted [Tissue]
   744   C0700106:Transplanted [Functional Concept]
   744   C1278978:Kidney [Body Part, Organ, or Organ Component]
   744   C1425014:NUDE [Gene or Genome]
   744   C1514845:KIDNEY [Tissue]
   711 E C1325531:capsule [Cell Component]
   711 E C1704652:Capsule [Qualitative Concept]
   711 E C1706433:{Capsule} [Quantitative Concept]
Processing 00000000.tx.87: Aliquots of islets were sedimented in a PE-50 polyethylene tube (BD PharMingen) attached to a 1-ml Hamilton syringe (Fisher), which allowed the injection of an islet pellet under the kidney capsule (50). 

Phrase: "Aliquots of islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "sedimented in a PE-50 polyethylene tube"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   748   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   748   C0175730:Tube [Medical Device]
   748   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   748   C1547937:Tube NOS [Intellectual Product]
   748   C1561954:tube [Conceptual Entity]
   748   C1704730:TUBE [Medical Device]
   714   C1550099:Sediment [Body Substance]

Phrase: "(BD PharMingen"

Phrase: ")"

Phrase: "attached to a 1-ml Hamilton syringe"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0039142:Syringe [Medical Device]
   748   C0231441:Attached [Finding]
   748   C0439526:/mL [Quantitative Concept]
   748   C1706072:Syringe [Manufactured Object]
   714 E C1314972:ATTACH [Intellectual Product]

Phrase: "(Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the injection of an islet pellet"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "under the kidney capsule"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0227616:kidney capsule [Body Part, Organ, or Organ Component]
   972 E C1281091:Renal capsule [Body Part, Organ, or Organ Component]
   861   C0006935:Capsule [Biomedical or Dental Material]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1325531:capsule [Cell Component]
   861   C1514845:KIDNEY [Tissue]
   861   C1704652:Capsule [Qualitative Concept]
   861   C1706433:{Capsule} [Quantitative Concept]
   789 E C0205151:Capsular [Spatial Concept]
   768 E C0027697:Nephritides [Disease or Syndrome]
   761 E C3000373:Capsula [Eukaryote]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.88: Then the islet pellets were transplanted beneath the left kidney capsule under methoxyflurane anesthesia (Metofane, Mallinckrodt Veterinary Inc., Mundelin, IL). 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the islet pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "transplanted beneath the left kidney capsule"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   790   C0227614:Left kidney [Body Part, Organ, or Organ Component]
   790   C0227616:kidney capsule [Body Part, Organ, or Organ Component]
   783   C0677491:kidney transplanted [Finding]
   783   C1261317:Transplanted kidney [Body Part, Organ, or Organ Component]
   767 E C0022671:Kidney transplant [Therapeutic or Preventive Procedure]
   767 E C0040745:Transplant kidney [Body Part, Organ, or Organ Component]
   762 E C1281091:Renal capsule [Body Part, Organ, or Organ Component]
   753   C0006935:Capsule [Biomedical or Dental Material]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0040732:transplanted [Therapeutic or Preventive Procedure]
   753   C0205091:Left [Spatial Concept]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0332835:transplanted [Tissue]
   753   C0700106:Transplanted [Functional Concept]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1325531:capsule [Cell Component]
   753   C1514845:KIDNEY [Tissue]
   753   C1552822:left [Functional Concept]
   753   C1704652:Capsule [Qualitative Concept]
   753   C1706433:{Capsule} [Quantitative Concept]

Phrase: "under methoxyflurane anesthesia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: "(Metofane,"

Phrase: "Mallinckrodt Veterinary Inc.,"

Phrase: "Mundelin,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.89: After transplantation, nonfasting blood glucose levels and body weights were measured weekly. 

Phrase: "After transplantation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: "nonfasting blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "body weights"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005910:Weights, Body [Organism Attribute]
       E   weight
  1000   C1305866:body weights [Diagnostic Procedure]
       E   weight
   861   C0043100:Weights [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   827 E C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "weekly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332174:Weekly [Temporal Concept]
Processing 00000000.tx.90: Blood glucose was measured with a portable glucose meter (Precision QID, Medisense Inc., St. Charles, MA) after tail snipping. 

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured with a portable glucose meter"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0444706:Measured [Qualitative Concept]
   753   C0475209:Meter [Quantitative Concept]
   753   C1706378:METER [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(Precision QID,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1547902:Precision [Temporal Concept]
   861   C1706245:Precision [Qualitative Concept]
   789 E C2939802:Precise [Pharmacologic Substance]

Phrase: "Medisense Inc.,"

Phrase: "St. Charles,"

Phrase: "MA)"

Phrase: "after"

Phrase: "tail snipping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1835838:SNIP [Gene or Genome]
Processing 00000000.tx.91: For measurement of plasma insulin levels 4weeks after transplantation, nonfasting blood samples were collected into heparinized capillary tubes, and plasma insulin was determined with a radioimmunoassay kit (Linco Research), using rat insulin as the standard. 

Phrase: "For measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of plasma insulin levels 4weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   723   C1276042:Plasma insulin level [Laboratory Procedure]

Phrase: "after transplantation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: "nonfasting blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected into heparinized capillary tubes,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0184108:capillary tubes [Medical Device]
   781 E C1707263:Tube Capillary [Medical Device]
   760   C0006901:Capillary [Body Part, Organ, or Organ Component]
   760   C0175730:tubes [Medical Device]
   760   C0935624:Capillary [Body Part, Organ, or Organ Component]
   760   C1280521:Capillary [Body Part, Organ, or Organ Component]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1547937:Tubes [Intellectual Product]
   760   C1704474:Tubes [Quantitative Concept]
   726 E C1561954:tube [Conceptual Entity]
   726 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined with a radioimmunoassay kit (Linco Research"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0034580:Radioimmunoassay [Laboratory Procedure]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat insulin as the standard."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.92: Also 4weeks after transplantation, islet grafts were excised under methoxyflurane anesthesia and lysed in RNA isolation solution Trizol (Invitrogen) for analysis of gene expression by RT-PCR as described above. 

Phrase: "Also 4weeks after transplantation,"

Phrase: "islet grafts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332835:Grafts [Tissue]
   861   C1527362:grafts [Qualitative Concept]
   827 E C0181074:{Graft} [Biomedical or Dental Material]
   827 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "excised under methoxyflurane anesthesia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   770   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   770   C0025688:Methoxyflurane [Organic Chemical,Pharmacologic Substance]
   715 E C0728777:Penthrane [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "lysed in RNA isolation solution Trizol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0024348:lysed [Pathologic Function]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0037633:Solution [Substance]
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "for analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "as described above."
Processing 00000000.tx.93: Data Analysis-- All results are presented as meanS.E. of at least three independent experiments. 

Phrase: "Data Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "-"

Phrase: "-"

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as meanS.E. of"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   726 E C0150312:Present [Quantitative Concept]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.94: Statistical analysis was performed using the unpaired Student's t test.  

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the unpaired Student's t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1710574:Unpaired t-Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0038492:student [Professional or Occupational Group]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1551041:student [Idea or Concept]
   812   C1552573:student [Intellectual Product]
Processing 00000000.tx.95: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Suppression of Insulin Gene Expression by Oxidative Stress in Rat Pancreatic Islets-- As shown in Fig. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Suppression of Insulin Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by Oxidative Stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "in Rat Pancreatic Islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "-"

Phrase: "-"

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.96: 1A, when pancreatic islets isolated from Sprague-Dawley rats were exposed to 0-50 M H2O2 for 48h, insulin mRNA levels were reduced in a dose-dependent manner, whereas levels of cyclophilin, -tubulin, glucagon, and rRNA were not affected, suggesting that insulin gene expression is particularly vulnerable to oxidative stress. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "when"

Phrase: "pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "isolated from Sprague-Dawley rats"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   862   C0034715:Rats, Sprague-Dawley [Mammal]
   806   C2699239:Sprague-Dawley [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "exposed to 0-50 M H2O2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced in a dose-dependent manner,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512045:Dose-dependent [Quantitative Concept]
   783   C1707814:Dose Reduced [Therapeutic or Preventive Procedure]
   753   C0178602:Dose [Quantitative Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "whereas"

Phrase: "levels of cyclophilin, -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "particularly vulnerable to oxidative stress."
Processing 00000000.tx.97: Also, DNA binding activity of PDX-1, an important transcription factor for insulin gene, was reduced by oxidative stress in association with a decrease of insulin mRNA levels (Fig. 1B). 

Phrase: "Also,"

Phrase: "DNA binding activity of PDX-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "an important transcription factor for insulin gene,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0812327:Transcription Factor Gene [Gene or Genome]
   778   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0040649:Gene Transcription [Genetic Function]
           Transcription
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "reduced by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "of insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: The specificity of the band for PDX-1 was confirmed by its ablation by PDX-1 antibody, but not by preimmune serum (lanes 5and 6), and by wild type competitor, but not by mutated type competitor (lanes 7and 8). 

Phrase: "The specificity of the band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "for PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "confirmed by its ablation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0547070:Ablation [Therapeutic or Preventive Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1261381:ablation [Therapeutic or Preventive Procedure]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "by PDX-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "but"

Phrase: "not by preimmune serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0229671:Serum [Body Substance]
   770   C1518422:Not [Functional Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "(lanes 5and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and by wild type competitor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "not by mutated type competitor"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332307:Type [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1705285:Mutated [Cell or Molecular Dysfunction]
   726 E C1513776:Mutate [Genetic Function]

Phrase: "(lanes 7and 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.99: Because it is known that oxidative stress triggers apoptosis in several cell types, after subjecting rat islets to 0-250 M H2O2 for 48h, cell viability was assessed with two different reagents, fluorescein diacetate (upper panel) and propidium iodide (lower panel). 

Phrase: "Because"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptosis in several cell types,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "after"

Phrase: "subjecting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "rat islets to 0-250 M H2O2"

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed with two different reagents,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0205448:Two [Quantitative Concept]
   760   C1516048:Assessed [Activity]
   760   C1705242:Different [Qualitative Concept]

Phrase: "fluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0046771:fluorescein diacetate [Organic Chemical]
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.100: Fluorescein diacetate enters cells and fluoresces green in viable cells; 

Phrase: "Fluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0046771:fluorescein diacetate [Organic Chemical]
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "green in viable cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.101: propidium iodide enters only dead or dying cells, binds to nucleic acids, and fluoresces red. 

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "only dead"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011065:Dead [Organism Function]

Phrase: "or"

Phrase: "dying cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "binds to nucleic acids,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0001128:Acids [Chemical]
   770   C0007610:Nucleic [Cell Component]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "red."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.102: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: 1C, there was no difference in cell viability after exposure to vehicle alone (left panel) and 50M H2O2 (middle panel), although we cannot exclude the possibility that this low concentration of H2O2 has some less obvious effect on cell viability. 

Phrase: "1C,"

Phrase: "there"

Phrase: "was"

Phrase: "no difference in cell viability after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0007620:Cell Viability [Cell Function]
   748   C0443348:viability [Qualitative Concept]

Phrase: "to vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "50M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "this low concentration of H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "has"

Phrase: "some less obvious effect on cell viability."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.104: In contrast, when islets were exposed to a higher concentration of H2O2 (250M), cell viability was markedly decreased (right panel). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to a higher concentration of H2O2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "(250M"

Phrase: ")"

Phrase: ","

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.105: These results suggest that suppressive effects of oxidative stress on insulin gene expression and PDX-1 DNA binding activity (Fig. 1, A and B) can occur separately from its effects upon cell viability. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that suppressive effects of oxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PDX-1 DNA binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "separately from its effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "upon cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.106: View larger version (50K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.107: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.108: Suppression of insulin gene expression by oxidative stress in rat pancreatic islets. 

Phrase: "Suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "in rat pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.109: A, after treatment of isolated islets (~100 islets) with 0-50 M H2O2 for 48h in RPMI 1640medium (11mM glucose), insulin mRNA levels were examined by RT-PCR. 

Phrase: "A,"

Phrase: "after"

Phrase: "treatment of isolated islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(~100 islets"

Phrase: ")"

Phrase: "with 0-50 M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "in RPMI 1640medium"

Phrase: "(11mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.110: Relative ratios of insulin/cyclophilin mRNA levels are expressed as meanS.E. in bar graphs with those of untreated islets being arbitrarily set at 100(n=3). 

Phrase: "Relative ratios of insulin/cyclophilin mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set at 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.111: B, after treatment with 0-50 M H2O2 for 48h, nuclear extracts were obtained from the islets, and gel-shift assays were performed. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "treatment with 0-50 M H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained from the islets,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "gel-shift assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0949632:Gel Shift Assay [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0333051:Shift [Functional Concept]
   827   C1382104:Gel [Substance]
   827   C2347509:Shift [Phenomenon or Process]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.112: A double-stranded oligonucleotide containing the rat insulin gene PDX-1 binding region was used as a binding probe. 

Phrase: "A double-stranded oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the rat insulin gene PDX-1 binding region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "used as a binding probe."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0182400:Probe [Medical Device]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.113: In lanes 5and 6, anti-PDX-1 antiserum and preimmune serum were employed, and in lanes 7and 8, wild type and mutated type competitor (100) were employed. 

Phrase: "In lanes 5and 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "anti-PDX-1 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "preimmune serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: ","

Phrase: "and in lanes 7and 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   726   C1708639:Lane [Spatial Concept]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutated type competitor"

Phrase: "(100"

Phrase: ")"

Phrase: "were"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.114: The arrow indicates the supershifted band. 

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the supershifted band."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]
Processing 00000000.tx.115: Similar results were obtained in three independent experiments. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in three independent experiments."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.116: C, isolated islets (~200 islets) were exposed to 0-250 M H2O2 for 48h and stained with fluorescein diacetate (upper panel) and propidium iodide (lower panel). 

Phrase: "C,"

Phrase: "isolated islets"

Phrase: "(~200 islets"

Phrase: ")"

Phrase: "were"

Phrase: "exposed to 0-250 M H2O2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "stained with fluorescein diacetate"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0046771:fluorescein diacetate [Organic Chemical]
   802   C0060520:Fluorescein stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Fluorescein
   770   C0369114:Diacetate [Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.117: Fluorescein diacetate enters cells and fluoresces green in viable cells; 

Phrase: "Fluorescein diacetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0046771:fluorescein diacetate [Organic Chemical]
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "green in viable cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.118: propidium iodide enters only dead or dying cells, binds to nucleic acids, and fluoresces red. 

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "enters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "only dead"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011065:Dead [Organism Function]

Phrase: "or"

Phrase: "dying cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "binds to nucleic acids,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0001128:Acids [Chemical]
   770   C0007610:Nucleic [Cell Component]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "fluoresces"

Phrase: "red."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]
Processing 00000000.tx.119: There was no difference in cell viability between exposure to vehicle alone (left panel) and 50M H2O2 (middle panel), whereas viability was markedly decreased (right panel) after treatment with a higher concentration of H2O2 (250M) (right panel). 

Phrase: "There"

Phrase: "was"

Phrase: "no difference in cell viability between exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0007620:Cell Viability [Cell Function]
   748   C0443348:viability [Qualitative Concept]

Phrase: "to vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "50M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "after"

Phrase: "treatment with a higher concentration of H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(250M"

Phrase: ")"

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.120: Activation of the Pathways JNK, p38 MAPK, and PKC by Oxidative Stress in Rat Pancreatic Islets-- Although several pathways such as JNK, p38 MAPK, and PKC are known to be activated by oxidative stress (25, 46) or high glucose (46-48) in several cell types, it is not known which kinase is activated in pancreatic islets. 

Phrase: "Activation of the Pathways JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC by Oxidative Stress"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   820 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Rat Pancreatic Islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "-"

Phrase: "-"

Phrase: "Although"

Phrase: "several pathways such as JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1621396:Pathways, JNK [Molecular Function]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated by oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "(25,"

Phrase: "46"

Phrase: ")"

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(46-48"

Phrase: ")"

Phrase: "in several cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "which kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated in pancreatic islets."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.121: Therefore, we examined signaling pathways that could be involved in suppression of insulin gene expression by oxidative stress. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0037080:Signal Pathways [Molecular Function]
   983   C0037083:signaling pathway [Cell Function]
   983   C0086982:Signaling Pathway [Molecular Function]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "involved in suppression of insulin gene expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.122: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.123: 2, A and B, expression levels of the phosphorylated forms of JNK and p38 MAPK were markedly increased in isolated islets treated with H2O2, whereas expression levels of total JNK and p38 MAPK were not affected by H2O2 treatment. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "expression levels of the phosphorylated forms of JNK"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   725   C1554102:Formal Expression [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in isolated islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]

Phrase: "treated with H2O2,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "whereas"

Phrase: "expression levels of total JNK"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by H2O2 treatment."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]
Processing 00000000.tx.124: Total PKC enzyme activity was also increased by treatment with H2O2 in isolated islets (Fig. 2C), although the increase of PKC activity was not so remarkable as those of phosphorylated forms of JNK and p38 MAPK. 

Phrase: "Total PKC enzyme activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C1150572:protein kinase C activity [Molecular Function]
   885   C1150527:protein kinase activity [Molecular Function]
   879   C3642159:Protein C Activity [Laboratory Procedure]
   876   C1537044:protein activity [Molecular Function]
   867 E C2261495:protein phosphokinase activity [Molecular Function]
   858   C1150423:kinase activity [Molecular Function]
   827   C0243102:enzyme activity [Molecular Function]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "increased by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "in isolated islets"

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the increase of PKC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not so remarkable as those of phosphorylated forms of JNK"

Phrase: "and"

Phrase: "p38 MAPK."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.125: Also, we examined the time course of insulin gene suppression by oxidative stress. 

Phrase: "Also,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the time course of insulin gene suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449247:Time course [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0750729:Course [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "by oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.126: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.127: 2D, when isolated islets were exposed to 50M H2O2 for 0-48 h, insulin mRNA levels were reduced in a time-dependent manner. 

Phrase: "2D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: "when"

Phrase: "isolated islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 0-48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced in a time-dependent manner."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0040223:Time [Temporal Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.128: Thus, activation of several pathways (JNK, p38 MAPK, and PKC) by oxidative stress (Fig. 2, A-C) preceded suppression of insulin gene expression (Fig. 2D). 

Phrase: "Thus,"

Phrase: "activation of several pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "(JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C) preceded suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.129: Additionally, as shown in Fig. 

Phrase: "Additionally,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.130: 2, E and F, phosphorylation of p38 MAPK and activation of PKC enzyme activity by H2O2 were completely blocked by the p38 MAPK inhibitor SB203580 (10M) or the PKC inhibitor GF109203X (5M), respectively, indicating that these reagents are acting as inhibitors in islets. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "E"

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "phosphorylation of p38 MAPK"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   713 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "activation of PKC enzyme activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   924   C3546691:activation of protein kinase C activity [Molecular Function]
           protein kinase C activation
   879   C1819040:activation of protein kinase activity [Cell Function]
   835   C2248395:activation of enzyme activity [Organism Function]
   804   C1819041:protein kinase activation [Cell Function]
   774   C0014429:Enzyme Activation [Molecular Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "by H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "were"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked by the p38 MAPK inhibitor SB203580"
Meta Candidates (Total=25; Excluded=5; Pruned=0; Remaining=20)
   833   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   824 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   760   C3537023:kinase inhibitor [Molecular Function]
   760   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0028778:Blocked [Pathologic Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   739   C0332206:Blocked [Functional Concept]
   739   C1879547:Activated [Activity]
   739   C1999216:Inhibitor [Qualitative Concept]
   739   C2983591:BLOCKED [Research Activity]
   706 E C1515877:Activate [Functional Concept]
   706 E C1533157:Block [Substance]
   706 E C1706084:Block [Geographic Area]
   706 E C2828370:Block [Quantitative Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "the PKC inhibitor GF109203X"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5M"

Phrase: ")"

Phrase: ","

Phrase: "respectively,"

Phrase: "indicating"

Phrase: "that"

Phrase: "these reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "are"

Phrase: "acting as inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756   C0079613:ACT [Therapeutic or Preventive Procedure]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "in islets."
Processing 00000000.tx.131: View larger version (32K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.133: Activation of the pathways JNK, p38 MAPK, and PKC in rat pancreatic islets. 

Phrase: "Activation of the pathways JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC in rat pancreatic islets."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   804 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.134: A and B, after treatment of isolated islets with 50M H2O2 for 0-120 min, whole cell extracts were obtained, and Western blot analysis was performed. 

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "treatment of isolated islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 50M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 0-120 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.135: JNK and p38 MAPK expression levels and their phosphorylated form levels were examined. 

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "p38 MAPK expression levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   829   C0428479:Protein level [Laboratory or Test Result]
   829   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   795   C0441889:Levels [Qualitative Concept]
   785   C3244092:expression level [Idea or Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "their phosphorylated form levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.136: Relative ratios of the phosphorylated form of JNK/total JNK levels and the phosphorylated form of p38 MAPK/total p38 MAPK levels are expressed as meanS.E. in line graphs with those of untreated islets being arbitrarily set at 1(n=3). 

Phrase: "Relative ratios of the phosphorylated form of JNK/total JNK levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C1264683:Relative ratio [Quantitative Concept]
   738   C0456603:Ratios [Quantitative Concept]
   738   C1610540:*Ratios [Quantitative Concept]
   704 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "the phosphorylated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of p38 MAPK/total p38 MAPK levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   845   C0428479:Protein level [Laboratory or Test Result]
   787   C0441889:Levels [Qualitative Concept]
   754 E C0456079:Level [Classification]
   754 E C1547707:Level [Geographic Area]
   754 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "expressed as meanS.E. in line graphs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C0205132:Line [Spatial Concept]
   748   C0681493:graphs [Intellectual Product]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.137: C, after treatment with 50M H2O2 for 0-120 min, cell lysates were obtained, and total PKC enzyme activity was examined. 

Phrase: "C,"

Phrase: "after"

Phrase: "treatment with 50M H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "for 0-120 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "total PKC enzyme activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C1150572:protein kinase C activity [Molecular Function]
   885   C1150527:protein kinase activity [Molecular Function]
   879   C3642159:Protein C Activity [Laboratory Procedure]
   876   C1537044:protein activity [Molecular Function]
   867 E C2261495:protein phosphokinase activity [Molecular Function]
   858   C1150423:kinase activity [Molecular Function]
   827   C0243102:enzyme activity [Molecular Function]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.138: Fold increase of total PKC activity is expressed in line graphs as meanS.E. with those of untreated islets being arbitrarily set at 1(n=4). 

Phrase: "Fold increase of total PKC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "expressed"

Phrase: "in line graphs as meanS.E."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681493:graphs [Intellectual Product]
   719 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: D, after treatment of isolated islets with 50M H2O2 for 0-48 h, insulin mRNA levels were examined by RT-PCR. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "after"

Phrase: "treatment of isolated islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 50M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 0-48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.140: Relative ratios of insulin/cyclophilin mRNA levels are expressed as meanS.E. in bar graphs with those of untreated islets being arbitrarily set at 100(n=3). 

Phrase: "Relative ratios of insulin/cyclophilin mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set at 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: E and F, islets were exposed to 50M H2O2 (or vehicle) for 30min with and without the p38 MAPK inhibitor SB203580 (10M) (E) or the PKC inhibitor GF109203X (5M) (F), and then phosphorylated form levels of p38 MAPK and total PKC activity were examined. 

Phrase: "E"

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for 30min"

Phrase: "with"

Phrase: "and without the p38 MAPK inhibitor SB203580"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   833   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   824 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   760   C3537023:kinase inhibitor [Molecular Function]
   760   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   739   C1515981:And [Idea or Concept]
   739   C1879547:Activated [Activity]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C1515877:Activate [Functional Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "(E)"

Phrase: "or"

Phrase: "the PKC inhibitor GF109203X"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5M"

Phrase: ")"

Phrase: "(F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "then phosphorylated form levels of p38 MAPK"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "total PKC activity"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   937   C1150572:protein kinase C activity [Molecular Function]
   888   C1150527:protein kinase activity [Molecular Function]
   888   C3642159:Protein C Activity [Laboratory Procedure]
   875   C1537044:protein activity [Molecular Function]
   870 E C2261495:protein phosphokinase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.142: Relative ratios of the phosphorylated form of p38 MAPK/total p38 MAPK levels and fold increase of total PKC activity are expressed in bar graphs as meanS.E. with those of untreated islets being arbitrarily set at 1(n=3). 

Phrase: "Relative ratios of the phosphorylated form"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1264683:Relative ratio [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "of p38 MAPK/total p38 MAPK levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   845   C0428479:Protein level [Laboratory or Test Result]
   787   C0441889:Levels [Qualitative Concept]
   754 E C0456079:Level [Classification]
   754 E C1547707:Level [Geographic Area]
   754 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "fold increase of total PKC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "are"

Phrase: "expressed in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681493:graphs [Intellectual Product]
   737 E C2698021:Graph [Conceptual Entity]

Phrase: "as meanS.E."

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.143: Effects of Adenovirus-mediated Overexpression of WT- and DN-JNK on Insulin Gene Expression-- To learn about the pathways involved in oxidative stress-mediated suppression of insulin gene expression, we tested the effects of candidate kinases. 

Phrase: "Effects of Adenovirus-mediated Overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on Insulin Gene Expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1705632:JNK [Gene or Genome]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "learn about the pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023185:learn [Mental Process]
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "involved in oxidative stress-mediated suppression of insulin gene expression,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C0017262:Gene Expression [Genetic Function]
   760   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C1337112:Insulin Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0038435:Stress [Finding]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0311404:Oxidative [Functional Concept]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1314939:Involved [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effects of candidate kinases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.144: To evaluate the possible implications of JNK in -cell dysfunction, we prepared WT-JNK and DN-JNK-expressing adenoviruses (Ad-WT-JNK and Ad-DN-JNK) and control adenovirus (Ad-GFP). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the possible implications of JNK in -cell dysfunction,"

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "WT-JNK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1150587:JNK [Molecular Function]
   827   C1367731:JNK [Gene or Genome]
   827   C1705632:JNK [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "DN-JNK-expressing adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0001483:Adenoviruses [Virus]
   766 E C0001486:Adenovirus [Disease or Syndrome]
   766 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ad-WT-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "Ad-DN-JNK)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "control adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001483:Adenovirus, NOS [Virus]
   861   C0001486:Adenovirus [Disease or Syndrome]
   861   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ad-GFP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0332583:Green [Qualitative Concept]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.145: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 3A depicts representative islets 72h after exposure to Ad-WT-JNK. 

Phrase: "3A"

Phrase: "depicts"

Phrase: "representative islets 72h after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1292423:72H [Temporal Concept]

Phrase: "to Ad-WT-JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.147: As seen by GFP in this light micrograph of whole floating islets, many cells are infected after exposure to Ad-WT-JNK, which also contains GFP. 

Phrase: "As"

Phrase: "seen by GFP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "in this light micrograph"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
   761   C0240341:Micrographia [Finding]
   761   C0596928:micrography [Laboratory Procedure]

Phrase: "of whole floating islets,"

Phrase: "many cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "infected after exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C0439663:Infected [Functional Concept]

Phrase: "to Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "which also"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.148: To confirm that infected WT- and DN-JNK adenoviruses can function appropriately in islets, whole cell extracts were isolated after infection with these adenoviruses and used for Western blotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that infected WT-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "DN-JNK adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0001483:Adenoviruses [Virus]
   771 E C0001486:Adenovirus [Disease or Syndrome]
   771 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "can"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "appropriately in islets,"

Phrase: "whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "isolated after infection"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with these adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0001483:Adenoviruses [Virus]
   966 E C0001486:Adenovirus [Disease or Syndrome]
   966 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "used for Western blotting."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.149: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: 3B, infection with Ad-WT-JNK or Ad-DN-JNK increased both total and phosphorylated JNK expression in islets as compared with islets infected with Ad-GFP. 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "infection with Ad-WT-JNK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0457463:infection type [Classification]
   753   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "or"

Phrase: "Ad-DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "both total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylated JNK expression in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "infected with Ad-GFP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.151: Moreover, phosphorylated JNK expression levels were further increased by H2O2 in both WT-JNK and DN-JNK overexpressing islets. 

Phrase: "Moreover,"

Phrase: "phosphorylated JNK expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "increased by H2O2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in both WT-JNK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1150587:JNK [Molecular Function]
   827   C1367731:JNK [Gene or Genome]
   827   C1705632:JNK [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "DN-JNK overexpressing islets."
Processing 00000000.tx.152: Also, as shown in Fig. 

Phrase: "Also,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.153: 3C, total and phosphorylated c-Jun expression levels were moderately increased by H2O2. 

Phrase: "3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450366:3c [Intellectual Product]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylated c-Jun expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C3244092:expression level [Idea or Concept]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "moderately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881878:Moderately [Qualitative Concept]

Phrase: "increased by H2O2."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.154: In contrast to JNK phosphorylation, c-Jun phosphorylation was clearly induced by H2O2 only in WT-JNK overexpressing islets but not in DN-JNK overexpressing islets. 

Phrase: "In contrast to JNK phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "c-Jun phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1155546:JUN phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0162508:c-Jun [Gene or Genome]

Phrase: "was"

Phrase: "clearly"

Phrase: "induced by H2O2 only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0205171:Only [Quantitative Concept]
   770   C0205263:Induced [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "in WT-JNK overexpressing islets"

Phrase: "but"

Phrase: "not in DN-JNK overexpressing islets."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   744   C0205160:Negative [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1513916:Negative [Finding]
   744   C1518422:Not [Functional Concept]
   744   C1527180:Dominant [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1705632:JNK [Gene or Genome]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]
   711   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.155: Considering that this DN-JNK is a kinase-dead mutant that can be phosphorylated but cannot phosphorylate c-Jun, these results are expected and thus suggest that these infected WT- and DN-JNK adenoviruses function appropriately in islets. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that"

Phrase: "this DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "a kinase-dead mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "but"

Phrase: "cannot"

Phrase: "phosphorylate"

Phrase: "c-Jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these infected WT-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "DN-JNK adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0001483:Adenoviruses [Virus]
   771 E C0001486:Adenovirus [Disease or Syndrome]
   771 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "appropriately in islets."
Processing 00000000.tx.156: Effects of the JNK pathway upon insulin gene transcription were examined by using these adenoviruses. 

Phrase: "Effects of the JNK pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "upon insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "were"

Phrase: "examined by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these adenoviruses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0001483:Adenoviruses [Virus]
   966 E C0001486:Adenovirus [Disease or Syndrome]
   966 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.157: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.158: 3C, the decrease of insulin mRNA levels by H2O2 was prevented by infection with Ad-DN-JNK, whereas insulin mRNA levels were decreased in the WT-JNK overexpressing islets compared with that in Ad-GFP-infected islets. 

Phrase: "3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450366:3c [Intellectual Product]

Phrase: "the decrease of insulin mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "by H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "prevented by infection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   756   C0309872:PREVENT [Pharmacologic Substance]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "whereas"

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "decreased in the WT-JNK overexpressing islets"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1547052:*Type [Quantitative Concept]
   744   C1705632:JNK [Gene or Genome]
   711 E C0547047:Decrease [Quantitative Concept]
   711   C1514559:overexpress [Genetic Function]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in Ad-GFP-infected islets."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   850   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   793   C0001483:Adenovirus, NOS [Virus]
   793   C0001486:Adenovirus [Disease or Syndrome]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   793   C0332285:In [Spatial Concept]
   793   C0332583:Green [Qualitative Concept]
   793   C0439663:Infected [Functional Concept]
   793   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.159: Also, as shown in Fig. 

Phrase: "Also,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.160: 3, D and E, the decrease of insulin mRNA levels by H2O2 was prevented by the antioxidant NAC, but no effect was seen with the p38 MAPK inhibitor SB203580 or the PKC inhibitor GF109203X. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E,"

Phrase: "the decrease of insulin mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "by H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "prevented by the antioxidant NAC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003402:Antioxidant [Pharmacologic Substance]
   760   C3538756:NAC [Gene or Genome]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "but"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "seen with the p38 MAPK inhibitor SB203580"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   833   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   824 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   760   C3537023:kinase inhibitor [Molecular Function]
   760   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205397:Seen [Qualitative Concept]
   739   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   739   C1879547:Activated [Activity]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C0042789:see [Organism Function]
   706 E C1515877:Activate [Functional Concept]
   706 E C1947903:See [Activity]

Phrase: "or"

Phrase: "the PKC inhibitor GF109203X."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.161: These results suggest that the JNK activation is likely to be involved in decrease of insulin gene expression by oxidative stress. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "involved in decrease of insulin gene expression"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.162: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.164: Effects of adenovirus-mediated overexpression of WT- and DN-JNK on insulin gene expression. 

Phrase: "Effects of adenovirus-mediated overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on insulin gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.165: A, isolated pancreatic islets (~300 islets) were infected with recombinant adenoviruses, Ad-WT-JNK, Ad-DN-JNK, or Ad-GFP (1108 pfu/ml), and cultured for 72h in RPMI 1640medium (11mM glucose). 

Phrase: "A,"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(~300 islets"

Phrase: ")"

Phrase: "were"

Phrase: "infected with recombinant adenoviruses,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0001483:Adenoviruses [Virus]
   770   C0439663:Infected [Functional Concept]
   770   C1514798:recombinant [Organism]
   737 E C0001486:Adenovirus [Disease or Syndrome]
   737 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(1108 pfu/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C2945590:unit/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]
   717   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cultured for 72h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1292423:72H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in RPMI 1640medium"

Phrase: "(11mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.166: Panel shows representative islets 72h after exposure to Ad-WT-JNK. 

Phrase: "Panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative islets 72h after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1292423:72H [Temporal Concept]

Phrase: "to Ad-WT-JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.167: As seen by GFP in this light micrograph of whole floating islets, many cells are infected after exposure to Ad-WT-JNK, which also contains GFP. 

Phrase: "As"

Phrase: "seen by GFP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "in this light micrograph"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
   761   C0240341:Micrographia [Finding]
   761   C0596928:micrography [Laboratory Procedure]

Phrase: "of whole floating islets,"

Phrase: "many cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "infected after exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C0439663:Infected [Functional Concept]

Phrase: "to Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "which also"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.168: B and C, 72h after infection of Ad-WT-JNK, Ad-DN-JNK, or Ad-GFP, islets were exposed to 50M H2O2 (or vehicle) for 30min. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "72h after infection of Ad-WT-JNK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1292423:72H [Temporal Concept]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for 30min."
Processing 00000000.tx.169: Total protein was obtained and used for Western blotting which was performed with the antibody for total and phosphorylated forms of JNK (B) and c-Jun (C). 

Phrase: "Total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "used for Western blotting"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "was"

Phrase: "performed with the antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylated forms of JNK ("
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c-Jun ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.170: Expression levels of total and phosphorylated forms of JNK and c-Jun are expressed as meanS.E. with those of control islets being arbitrarily set at 1(n=3). 

Phrase: "Expression levels of total"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C3244092:expression level [Idea or Concept]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphorylated forms of JNK"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "with those"

Phrase: "of control islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.171: D, 48h after exposure to Ad-GFP, Ad-WT-JNK, Ad-DN-JNK, islets were exposed to 50M H2O2 (or vehicle) for another 48h, and insulin mRNA levels were examined by RT-PCR. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "48h after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "to Ad-GFP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   876   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0001483:Adenovirus, NOS [Virus]
   799   C0001486:Adenovirus [Disease or Syndrome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0332583:Green [Qualitative Concept]
   799   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C1883351:To [Qualitative Concept]

Phrase: "Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for another 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.172: E, after exposure to 50M H2O2 (or vehicle) for 48h with and without p38 MAPK inhibitor SB203580 (10M), PKC inhibitor GF109203X (5M), or antioxidant NAC (10mM), insulin mRNA levels were examined. 

Phrase: "E,"

Phrase: "after"

Phrase: "exposure to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "with"

Phrase: "and without p38 MAPK inhibitor SB203580"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   849   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   849   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   838 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   764   C3537023:kinase inhibitor [Molecular Function]
   764   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   742   C1515981:And [Idea or Concept]
   742   C1879547:Activated [Activity]
   742   C1999216:Inhibitor [Qualitative Concept]
   708 E C1515877:Activate [Functional Concept]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "PKC inhibitor GF109203X"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5M"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "antioxidant NAC (10mM"

Phrase: ")"

Phrase: ","

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.173: Relative ratios of insulin/cyclophilin mRNA levels are expressed as meanS.E. in bar graphs with those of islets infected with Ad-GFP (without H2O2 treatment) being arbitrarily set at 100(n=4). 

Phrase: "Relative ratios of insulin/cyclophilin mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of islets"

Phrase: "infected with Ad-GFP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "without H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set at 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: *, p<0.01. 

Phrase: "*,"

Phrase: "p<0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.175: Involvement of the JNK Pathway in Reduction of Insulin Gene Expression by Glucosamine-- Glucose metabolism through the hexosamine pathway has been implicated in many of the adverse effects of chronic hyperglycemia (51-54). 

Phrase: "Involvement of the JNK Pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in Reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of Insulin Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by Glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "--"

Phrase: "Glucose metabolism through the hexosamine pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596620:glucose metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in many of the adverse effects of chronic hyperglycemia"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001688:adverse effects [Functional Concept]
   760   C0342300:Chronic hyperglycaemia [Pathologic Function]
   760   C0879626:Adverse effects [Pathologic Function]
   739   C0020456:Hyperglycaemia [Disease or Syndrome]
   739   C0205191:chronic [Temporal Concept]
   739   C1280500:effects [Qualitative Concept]
   726 E C0559546:Adverse Effect [Finding]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "(51-54"

Phrase: ")."
Processing 00000000.tx.176: Increased glucose flux through this pathway results in the generation of an amino sugar, glucosamine 6-phosphate, which is formed from fructose 6-phosphate by glutamine:fructose-6-phosphate amidotransferase and leads to increase of O-linked glycosylation of many proteins (55, 56). 

Phrase: "Increased glucose flux through this pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "results in the generation of an amino sugar,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002531:Amino sugar [Biologically Active Substance,Carbohydrate]
   744   C0007004:Sugar [Carbohydrate]
   744   C0079411:Generation [Temporal Concept]
   744   C0242209:Sugar [Carbohydrate,Pharmacologic Substance]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C3146294:Generation [Activity]

Phrase: "glucosamine 6-phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061393:glucosamine 6-phosphate [Biologically Active Substance,Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "formed from fructose 6-phosphate"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C0060775:fructose-6-phosphate [Biologically Active Substance,Carbohydrate]
   797   C0016765:fructose phosphate [Carbohydrate]
   760   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0205431:Formed [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "by glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ":"

Phrase: "fructose-6-phosphate amidotransferase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0060775:fructose-6-phosphate [Biologically Active Substance,Carbohydrate]
   708   C0016765:fructose phosphate [Carbohydrate]

Phrase: "and"

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase of O-linked glycosylation of many proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1621325:protein O-linked glycosylation [Molecular Function]
   767   C0376322:glycosylation proteins [Molecular Function]
           Glycosylation
   750   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017982:glycosylation [Natural Phenomenon or Process]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442805:Increase [Functional Concept]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.177: Because it is known that glucosamine induces oxidative stress and is possibly involved in -cell dysfunction in diabetes (35), we tested whether JNK is involved in -cell dysfunction produced by glucosamine. 

Phrase: "Because"

Phrase: "it"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell dysfunction in diabetes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "produced by glucosamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.178: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.179: 4A, expression level of phosphorylated form of JNK was increased in islets treated with glucosamine, whereas expression level of total JNK was not affected by glucosamine treatment. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "expression level of phosphorylated form of JNK"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
   738   C1554102:Formal Expression [Idea or Concept]

Phrase: "was"

Phrase: "increased in islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "treated with glucosamine,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "whereas"

Phrase: "expression level of total JNK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by glucosamine treatment."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]
Processing 00000000.tx.180: Also, as shown in Fig. 

Phrase: "Also,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.181: 4B, insulin mRNA level was reduced by glucosamine treatment, and the suppressive effect of glucosamine on insulin gene expression was reduced by the antioxidant NAC (Fig. 4B). 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "insulin mRNA level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0202098:Insulin level [Laboratory Procedure]
   913   C0428405:insulin level [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced by glucosamine treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "the suppressive effect of glucosamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "reduced by the antioxidant NAC (Fig. 4B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0003402:Antioxidant [Pharmacologic Substance]
   748   C0349966:Fig [Food]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0450375:4b [Intellectual Product]
   748   C1337208:FIG [Food]
   748   C3538756:NAC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.182: These results imply that glucosamine decreases insulin mRNA level mainly through the induction of oxidative stress, although we cannot exclude the possibility that some other effect of glucosamine also contributes to suppression of insulin gene expression. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "insulin mRNA level mainly through the induction of oxidative stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C1319127:Level of stress [Finding]
           Stress level
   757   C0202098:Insulin level [Laboratory Procedure]
   757   C0428405:insulin level [Laboratory or Test Result]
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "some other effect of glucosamine also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "contributes to suppression of insulin gene expression."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.183: Furthermore, as shown in Fig. 

Phrase: "Furthermore,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.184: 4C, the decrease of insulin gene expression by glucosamine was prevented by infection with Ad-DN-JNK. 

Phrase: "4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the decrease of insulin gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "by glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "prevented by infection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   756   C0309872:PREVENT [Pharmacologic Substance]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with Ad-DN-JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.185: Thus, these results strengthen the hypothesis that DN-JNK protects insulin gene expression from oxidative stress. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "strengthen"

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "protects"

Phrase: "insulin gene expression from oxidative stress."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   790   C1337112:Insulin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.186: View larger version (37K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 4.  

Phrase: "4."
Processing 00000000.tx.188: Activation of the JNK pathway and suppression of insulin gene expression by glucosamine. 

Phrase: "Activation of the JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by glucosamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.189: A, after treatment of isolated islets with 10mM glucosamine for 0-120 min, whole cell extracts were obtained, and Western blot analyses were performed. 

Phrase: "A,"

Phrase: "after"

Phrase: "treatment of isolated islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 10mM glucosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "for 0-120 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "Western blot analyses"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.190: Levels of JNK expression level and its phosphorylated form were examined. 

Phrase: "Levels of JNK expression level"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its phosphorylated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.191: Relative ratios of the phosphorylated form of JNK/total JNK levels are expressed as meanS.E. in line graphs with those of untreated islets being arbitrarily set at 1(n=3). 

Phrase: "Relative ratios of the phosphorylated form of JNK/total JNK levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C1264683:Relative ratio [Quantitative Concept]
   738   C0456603:Ratios [Quantitative Concept]
   738   C1610540:*Ratios [Quantitative Concept]
   704 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as meanS.E. in line graphs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C0205132:Line [Spatial Concept]
   748   C0681493:graphs [Intellectual Product]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of untreated islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: B, islets were exposed to 10mM glucosamine (or vehicle) for 48h with or without NAC (10mM), and insulin mRNA levels were examined by RT-PCR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 10mM glucosamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "with"

Phrase: "or without NAC (10mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538756:NAC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.193: C, 48h after exposure to Ad-GFP or Ad-DN-JNK, islets were exposed to 10mM glucosamine (or vehicle) for another 48h, and insulin mRNA levels were examined by RT-PCR. 

Phrase: "C,"

Phrase: "48h after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "to Ad-GFP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   876   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0001483:Adenovirus, NOS [Virus]
   799   C0001486:Adenovirus [Disease or Syndrome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0332583:Green [Qualitative Concept]
   799   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C1883351:To [Qualitative Concept]

Phrase: "or"

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 10mM glucosamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0017718:Glucosamine [Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for another 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.194: Relative ratios of insulin/cyclophilin mRNA levels are expressed as meanS.E. in bar graphs with those of control islets being arbitrarily set at 100(n=3). 

Phrase: "Relative ratios of insulin/cyclophilin mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of control islets"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set at 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: *, p<0.01. 

Phrase: "*,"

Phrase: "p<0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.196: Effects of Adenoviral Overexpression of WT- and DN-JNK on Glucose-stimulated Insulin Secretion-- To see if JNK is involved in the reduction of insulin secretion, static incubations were performed after exposure to Ad-WT-JNK or Ad-DN-JNK. 

Phrase: "Effects of Adenoviral Overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on Glucose-stimulated Insulin Secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1150587:JNK [Molecular Function]
   742   C1367731:JNK [Gene or Genome]
   742   C1705632:JNK [Gene or Genome]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "if"

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "involved in the reduction of insulin secretion,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "static incubations"

Phrase: "were"

Phrase: "performed after exposure"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to Ad-WT-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-DN-JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.197: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.198: 5, after exposure to H2O2, glucose-stimulated insulin secretion was decreased. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "after"

Phrase: "exposure to H2O2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.199: The decrease of insulin secretion was prevented by infection with Ad-DN-JNK, whereas insulin secretion was decreased in the WT-JNK overexpressing islets compared with that in Ad-GFP-infected islets. 

Phrase: "The decrease of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "prevented by infection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   756   C0309872:PREVENT [Pharmacologic Substance]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "whereas"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased in the WT-JNK overexpressing islets"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1547052:*Type [Quantitative Concept]
   744   C1705632:JNK [Gene or Genome]
   711 E C0547047:Decrease [Quantitative Concept]
   711   C1514559:overexpress [Genetic Function]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in Ad-GFP-infected islets."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   850   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   793   C0001483:Adenovirus, NOS [Virus]
   793   C0001486:Adenovirus [Disease or Syndrome]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   793   C0332285:In [Spatial Concept]
   793   C0332583:Green [Qualitative Concept]
   793   C0439663:Infected [Functional Concept]
   793   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.200: These results were correlated with change of insulin mRNA levels in islets (Fig. 3C). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "correlated with change of insulin mRNA levels"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   774   C0202098:insulin levels [Laboratory Procedure]
   774   C0428405:insulin levels [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0392747:Change [Functional Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1705241:Change [Quantitative Concept]
   748   C1707520:Correlated [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in islets"

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Thus, we assume that preservation of insulin secretion from oxidative stress is, at least in part, due to protection of insulin mRNA level by DN-JNK. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "assume"

Phrase: "that preservation of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033085:Preservation [Laboratory Procedure]
   760   C1514402:Preservation [Laboratory Procedure]

Phrase: "from oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "due to protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "of insulin mRNA level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0202098:Insulin level [Laboratory Procedure]
   913   C0428405:insulin level [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "by DN-JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.202: Taken together, these results indicate that overexpression of DN-JNK can protect both insulin gene expression and secretion from oxidative stress. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that overexpression of DN-JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "can"

Phrase: "protect"

Phrase: "both insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretion from oxidative stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
Processing 00000000.tx.203: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.204: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.205: Effects of adenoviral overexpression of WT- and DN-JNK on glucose-stimulated insulin secretion. 

Phrase: "Effects of adenoviral overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on glucose-stimulated insulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1150587:JNK [Molecular Function]
   742   C1367731:JNK [Gene or Genome]
   742   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.206: Forty eight hours after infection with Ad-WT-JNK, Ad-DN-JNK, or Ad-GFP, islets were exposed to 50M H2O2 (or vehicle) for another 48h, and then glucose-stimulated insulin secretion was examined over 60min using static incubation with batches of 50islets, comparing 2.8and 16.7mM glucose. 

Phrase: "Forty eight hours after infection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "with Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for another 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "then glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "examined over 60min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "static incubation with batches of 50islets,"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "2.8and 16.7mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.207: Amounts of secreted insulin (pg/min/islet) are expressed as meanS.E. in bar graphs (n=3). 

Phrase: "Amounts of secreted insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(pg/min/islet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2827932:pg/min [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.208: *, p<0.01. 

Phrase: "*,"

Phrase: "p<0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.209: Effects of Adenoviral Overexpression of WT- and DN-JNK on PDX-1 DNA Binding Activity-- Because gene expression and DNA binding activity of PDX-1 are reduced by oxidative stress provoked in the diabetic state, in association with suppression of insulin gene expression (32, 33), we examined the effects of the JNK pathway on PDX-1 DNA binding activity with the gel-shift assay. 

Phrase: "Effects of Adenoviral Overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on PDX-1 DNA Binding Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1149291:JNK binding [Molecular Function]
   739   C1150587:JNK [Molecular Function]
   739   C1367731:JNK [Gene or Genome]
   739   C1705632:JNK [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "DNA binding activity of PDX-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "reduced by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "provoked in the diabetic state,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0241863:DIABETIC [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1444748:Provoked [Qualitative Concept]
   760   C3148680:State [Geographic Area]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of the JNK pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on PDX-1 DNA binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "with the gel-shift assay."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0949632:Gel Shift Assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0243073:assay [Qualitative Concept]
   827   C0333051:Shift [Functional Concept]
   827   C1382104:Gel [Substance]
   827   C1510438:Assay [Laboratory Procedure]
   827   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.210: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.211: 6, A and B, oxidative stress-mediated suppression of PDX-1 DNA binding activity was reduced by DN-JNK overexpression or the antioxidant NAC but not by the p38 MAPK inhibitor SB203580 or the PKC inhibitor GF109203X. 

Phrase: "6,"

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "oxidative stress-mediated suppression of PDX-1 DNA binding activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]

Phrase: "was"

Phrase: "reduced by DN-JNK overexpression"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1514559:Overexpression [Genetic Function]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "the antioxidant NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538756:NAC [Gene or Genome]

Phrase: "but"

Phrase: "not by the p38 MAPK inhibitor SB203580"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   833   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1513344:Mitogen-Activated Protein Kinase Inhibitor [Pharmacologic Substance]
   824 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   806   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   760   C3537023:kinase inhibitor [Molecular Function]
   760   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0026249:Mitogen [Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]
   739   C1518422:Not [Functional Concept]
   739   C1879547:Activated [Activity]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "the PKC inhibitor GF109203X."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]
   771   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   722   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   722   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.212: Furthermore, WT-JNK overexpression reduced PDX-1 DNA binding activity. 

Phrase: "Furthermore,"

Phrase: "WT-JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "PDX-1 DNA binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.213: These results further implicate JNK in oxidative stress-mediated suppression of PDX-1 DNA binding activity and of insulin gene expression. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "implicate"

Phrase: "JNK in oxidative stress-mediated suppression of PDX-1 DNA binding activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C1149291:JNK binding [Molecular Function]
   736   C1150587:JNK [Molecular Function]
   736   C1367731:JNK [Gene or Genome]
   736   C1705632:JNK [Gene or Genome]

Phrase: "and of insulin gene expression."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0017262:Gene Expression [Genetic Function]
   806   C1337112:Insulin Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.214: View larger version (81K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.215: 6.  

Phrase: "6."
Processing 00000000.tx.216: Effects of adenoviral overexpression of WT- and DN-JNK on PDX-1 DNA binding activity. 

Phrase: "Effects of adenoviral overexpression of WT-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "DN-JNK on PDX-1 DNA binding activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1149291:JNK binding [Molecular Function]
   739   C1150587:JNK [Molecular Function]
   739   C1367731:JNK [Gene or Genome]
   739   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.217: A, 48h after exposure to Ad-WT-JNK, Ad-DN-JNK, or Ad-GFP, islets were exposed to 50M H2O2 (or vehicle) for another 48h, and then nuclear extracts were obtained and gel-shift assays were performed. 

Phrase: "A,"

Phrase: "48h after exposure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "to Ad-WT-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "or"

Phrase: "Ad-GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 50M H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "for another 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "then nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "gel-shift assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0949632:Gel Shift Assay [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0333051:Shift [Functional Concept]
   827   C1382104:Gel [Substance]
   827   C2347509:Shift [Phenomenon or Process]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.218: B, after treatment with 50M H2O2 (or vehicle) and SB203580 (10M), GF109203X (5M), and NAC (10mM) for 48h, gel-shift assays were performed. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "treatment with 50M H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SB203580"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "GF109203X"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: "(5M"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "NAC (10mM"

Phrase: ")"

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "gel-shift assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0949632:Gel Shift Assay [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0333051:Shift [Functional Concept]
   827   C1382104:Gel [Substance]
   827   C2347509:Shift [Phenomenon or Process]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.219: A double-stranded oligonucleotide containing the rat insulin gene PDX-1 binding region was used as a binding probe. 

Phrase: "A double-stranded oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the rat insulin gene PDX-1 binding region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "used as a binding probe."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0182400:Probe [Medical Device]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.220: Similar results were obtained in three independent experiments. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in three independent experiments."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.221: Effects of Transplantation of DN-JNK Overexpressing Islets on Insulin Gene Expression and Glucose Tolerance in STZ-induced Diabetic Mice-- Because it is currently not possible to culture isolated islets for a long enough period to fully bring out the effects of glucose toxicity, we performed islet transplantation into diabetic mice to examine whether DN-JNK can protect -cells from the toxic effects of hyperglycemia and to explore the potential therapeutic application for islet transplantation. 

Phrase: "Effects of Transplantation of DN-JNK Overexpressing Islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on Insulin Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Glucose Tolerance in STZ-induced Diabetic Mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0178665:Glucose tolerance [Physiologic Function]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C1704410:Tolerance [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "it"

Phrase: "is"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "not possible to culture isolated islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332149:Possible [Qualitative Concept]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]

Phrase: "for a long enough period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "to fully"

Phrase: "bring"

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the effects of glucose toxicity,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C1158774:glucose effect [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   745   C0600688:Toxic effect [Injury or Poisoning]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "islet transplantation into diabetic mice to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0079646:Transplantation, Islet [Therapeutic or Preventive Procedure]
   753   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   753   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   753   C0040733:transplantation [Functional Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "can"

Phrase: "protect -"

Phrase: "cells from the toxic effects of hyperglycemia"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the potential therapeutic application for islet transplantation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0185125:Application [Health Care Activity]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.222: Isolated rat islets were infected with Ad-DN-JNK or Ad-GFP and cultured for 2days; 

Phrase: "Isolated rat islets"

Phrase: "were"

Phrase: "infected with Ad-DN-JNK"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "Ad-GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "cultured for 2days"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.223: then 500islets were transplanted under kidney capsules of STZ-induced diabetic Swiss nude mice. 

Phrase: "then 500islets"

Phrase: "were"

Phrase: "transplanted under kidney capsules of STZ-induced diabetic Swiss nude mice."
Meta Candidates (Total=31; Excluded=6; Pruned=0; Remaining=25)
   761   C0227616:Capsule of kidney [Body Part, Organ, or Organ Component]
           capsule kidney
   761   C1281091:Capsule of kidney [Body Part, Organ, or Organ Component]
       E   Renal capsule
   759   C0022671:Transplant of kidney [Therapeutic or Preventive Procedure]
       E   Kidney transplant
   756   C0025932:Mice, Nude [Mammal]
   754   C0162416:Swiss Mice [Mammal]
   754   C0677491:kidney transplanted [Finding]
   754   C1261317:Transplanted kidney [Body Part, Organ, or Organ Component]
   738   C0006935:Capsules [Biomedical or Dental Material]
   738   C0022646:Kidney [Body Part, Organ, or Organ Component]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   738   C0040732:transplanted [Therapeutic or Preventive Procedure]
   738   C0205263:Induced [Functional Concept]
   738   C0227665:kidney [Body Part, Organ, or Organ Component]
   738   C0241315:Swiss [Population Group]
   738   C0241863:DIABETIC [Finding]
   738   C0332835:transplanted [Tissue]
   738   C0700106:Transplanted [Functional Concept]
   738   C1278978:Kidney [Body Part, Organ, or Organ Component]
   738   C1425014:NUDE [Gene or Genome]
   738   C1514845:KIDNEY [Tissue]
   737 E C0040745:Transplant kidney [Body Part, Organ, or Organ Component]
   737   C1517673:Mouse Kidney [Tissue]
   704 E C1325531:capsule [Cell Component]
   704 E C1704652:Capsule [Qualitative Concept]
   704 E C1706433:{Capsule} [Quantitative Concept]
Processing 00000000.tx.224: Whereas 500islets cultured overnight can usually normalize glucose levels in diabetic mice, we anticipated that the viral infection and longer time in culture would produce some alteration of islet cells, thus making these 500islets a more marginal number. 

Phrase: "Whereas"

Phrase: "500islets"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "can"

Phrase: "usually"

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "glucose levels in diabetic mice,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0428548:glucose levels [Laboratory or Test Result]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "anticipated"

Phrase: "that"

Phrase: "the viral infection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0042769:Viral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   861   C0521026:Viral [Functional Concept]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "and"

Phrase: "longer time in culture"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "would"

Phrase: "produce"

Phrase: "some alteration of islet cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515926:Alteration [Idea or Concept]

Phrase: "thus"

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "these 500islets"

Phrase: "a more marginal number."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.225: Blood glucose levels were not sufficiently decreased by transplantation of islets infected with Ad-GFP, which was probably due to toxic effects of hyperglycemia upon a marginal islet number but were markedly decreased by Ad-DN-JNK (Fig. 7A). 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "not sufficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decreased by transplantation of islets"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0079646:islets transplantation [Therapeutic or Preventive Procedure]
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "infected with Ad-GFP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "was"

Phrase: "probably due to toxic effects of hyperglycemia"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   748   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   748   C0750492:Probably [Idea or Concept]
   748   C1280500:effects [Qualitative Concept]
   748   C1407029:Toxic [Qualitative Concept]
   748   C3146286:Due [Idea or Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "upon a marginal islet number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "but"

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased by Ad-DN-JNK (Fig. 7A"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   764   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   742   C0205160:Negative [Qualitative Concept]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0349966:Fig [Food]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C1150587:JNK [Molecular Function]
   742   C1337208:FIG [Food]
   742   C1367731:JNK [Gene or Genome]
   742   C1513916:Negative [Finding]
   742   C1527180:Dominant [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1705632:JNK [Gene or Genome]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.226: There was no clear difference in weight gain between these two groups (Fig. 7B). 

Phrase: "There"

Phrase: "was"

Phrase: "no clear difference in weight gain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between these two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.227: Plasma insulin levels examined 4weeks after transplantation showed a tendency to be preserved by infection with Ad-DN-JNK, although statistical significance was not reached (Fig. 7C). 

Phrase: "Plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "4weeks after transplantation"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a tendency to"

Phrase: "be"

Phrase: "preserved by infection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C0033085:Preserved [Laboratory Procedure]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with Ad-DN-JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "although"

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.228: To examine how long the overexpressed JNK lasts in the transplanted islets, we measured JNK mRNA levels before and 4weeks after transplantation of Ad-DN-JNK-infected islets. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "how long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205166:Long [Qualitative Concept]
   861   C1706317:Long [Qualitative Concept]

Phrase: "the overexpressed JNK lasts in the transplanted islets,"

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "JNK mRNA levels before"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "4weeks after transplantation"

Phrase: "of Ad-DN-JNK-infected islets."
Processing 00000000.tx.229: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.230: 7D, in Ad-GFP-infected islets JNK expression levels were relatively low both before and 4weeks after transplantation (lanes 1and 3). 

Phrase: "7D,"

Phrase: "in Ad-GFP-infected islets JNK expression levels"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   830   C1171362:protein expression [Genetic Function]
   830   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   823   C0428479:Protein level [Laboratory or Test Result]
   816   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   788   C0001483:Adenovirus, NOS [Virus]
   788   C0001486:Adenovirus [Disease or Syndrome]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0150312:In [Quantitative Concept]
   788   C0185117:Expression [Therapeutic or Preventive Procedure]
   788   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   788   C0332285:In [Spatial Concept]
   788   C0332583:Green [Qualitative Concept]
   788   C0439663:Infected [Functional Concept]
   788   C0441889:Levels [Qualitative Concept]
   788   C1150587:JNK [Molecular Function]
   788   C1367731:JNK [Gene or Genome]
   788   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   788   C1705632:JNK [Gene or Genome]
   768   C3244092:expression level [Idea or Concept]
   755 E C0456079:Level [Classification]
   755 E C1547707:Level [Geographic Area]
   755 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "relatively low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "both before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "and"

Phrase: "4weeks after transplantation"

Phrase: "(lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.231: After infection of Ad-DN-JNK (before transplantation), however, JNK expression was markedly increased (lane 2); 

Phrase: "After infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "of Ad-DN-JNK ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]

Phrase: "before transplantation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "JNK expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.232: 4weeks after transplantation JNK expression in the grafts was decreased by 32% but was still clearly detected (lane 4). 

Phrase: "4weeks after transplantation JNK expression"

Phrase: "in the grafts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332835:Grafts [Tissue]
  1000   C1527362:grafts [Qualitative Concept]
   966 E C0181074:{Graft} [Biomedical or Dental Material]
   966 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "decreased by 32%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "still clearly"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.233: Furthermore, insulin mRNA levels in either islet pellets or islet grafts were examined before and 4weeks after transplantation. 

Phrase: "Furthermore,"

Phrase: "insulin mRNA levels in either islet pellets"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0202098:insulin levels [Laboratory Procedure]
   774   C0428405:insulin levels [Laboratory or Test Result]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "islet grafts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332835:Grafts [Tissue]
   861   C1527362:grafts [Qualitative Concept]
   827 E C0181074:{Graft} [Biomedical or Dental Material]
   827 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "examined before"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "4weeks after transplantation."
Processing 00000000.tx.234: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.235: 7E, there was no difference in insulin mRNA levels between Ad-GFP and Ad-DN-JNK group before transplantation (2days after exposure of isolated islets to each adenovirus). 

Phrase: "7E,"

Phrase: "there"

Phrase: "was"

Phrase: "no difference in insulin mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between Ad-GFP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   876   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0001483:Adenovirus, NOS [Virus]
   799   C0001486:Adenovirus [Disease or Syndrome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0205103:Between [Spatial Concept]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0332583:Green [Qualitative Concept]
   799   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Ad-DN-JNK group before transplantation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "(2days after exposure of isolated islets"

Phrase: "to each adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.236: Four weeks after transplantation of islets infected with Ad-GFP, insulin mRNA levels in islet grafts were clearly decreased compared with those before transplantation but were relatively preserved by DN-JNK overexpression (Fig. 7E). 

Phrase: "Four weeks after transplantation of islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]

Phrase: "infected with Ad-GFP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "insulin mRNA levels in islet grafts"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "clearly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with those before transplantation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]
   760   C1707455:Compared [Activity]

Phrase: "but"

Phrase: "were"

Phrase: "relatively"

Phrase: "preserved by DN-JNK overexpression"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0033085:Preserved [Laboratory Procedure]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1514559:Overexpression [Genetic Function]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "(Fig. 7E"

Phrase: ")."
Processing 00000000.tx.237: These results suggest DN-JNK can protect -cells from some of the toxic effects of hyperglycemia during this transplant period. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "can"

Phrase: "protect -"

Phrase: "cells from some of the toxic effects of hyperglycemia"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "during this transplant period."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.238: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.239: 7.  

Phrase: "7."
Processing 00000000.tx.240: Effects of transplantation of DN-JNK overexpressing islets on insulin gene expression and glucose tolerance in STZ-induced diabetic mude mice. 

Phrase: "Effects of transplantation of DN-JNK overexpressing islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "glucose tolerance in STZ-induced diabetic mude mice."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0178665:Glucose tolerance [Physiologic Function]
   744   C0013220:Tolerance [Finding]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0020963:Tolerance [Pathologic Function]
   744   C0220929:tolerance [Mental Process]
   744   C0231197:Tolerance [Physiologic Function]
   744   C1704410:Tolerance [Qualitative Concept]
Processing 00000000.tx.241: A and B, isolated rat islets were infected with Ad-DN-JNK or Ad-GFP and cultured for 2days; 

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "isolated rat islets"

Phrase: "were"

Phrase: "infected with Ad-DN-JNK"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "or"

Phrase: "Ad-GFP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "cultured for 2days"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.242: then 500islets were transplanted under the kidney capsules of STZ-induced diabetic Swiss nude mice. 

Phrase: "then 500islets"

Phrase: "were"

Phrase: "transplanted under the kidney capsules of STZ-induced diabetic Swiss nude mice."
Meta Candidates (Total=31; Excluded=6; Pruned=0; Remaining=25)
   756   C0227616:Capsule of kidney [Body Part, Organ, or Organ Component]
           capsule kidney
   756   C1281091:Capsule of kidney [Body Part, Organ, or Organ Component]
       E   Renal capsule
   755   C0022671:Transplant of kidney [Therapeutic or Preventive Procedure]
       E   Kidney transplant
   753   C0025932:Mice, Nude [Mammal]
   751   C0162416:Swiss Mice [Mammal]
   751   C0677491:kidney transplanted [Finding]
   751   C1261317:Transplanted kidney [Body Part, Organ, or Organ Component]
   736   C0006935:Capsules [Biomedical or Dental Material]
   736   C0022646:Kidney [Body Part, Organ, or Organ Component]
   736   C0025914:Mice [Mammal]
   736   C0025929:mice [Mammal]
   736   C0026809:Mice [Mammal]
   736   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   736   C0040732:transplanted [Therapeutic or Preventive Procedure]
   736   C0205263:Induced [Functional Concept]
   736   C0227665:kidney [Body Part, Organ, or Organ Component]
   736   C0241315:Swiss [Population Group]
   736   C0241863:DIABETIC [Finding]
   736   C0332835:transplanted [Tissue]
   736   C0700106:Transplanted [Functional Concept]
   736   C1278978:Kidney [Body Part, Organ, or Organ Component]
   736   C1425014:NUDE [Gene or Genome]
   736   C1514845:KIDNEY [Tissue]
   734 E C0040745:Transplant kidney [Body Part, Organ, or Organ Component]
   734   C1517673:Mouse Kidney [Tissue]
   703 E C1325531:capsule [Cell Component]
   703 E C1704652:Capsule [Qualitative Concept]
   703 E C1706433:{Capsule} [Quantitative Concept]
Processing 00000000.tx.243: After transplantation, nonfasting blood glucose levels and body weights were measured weekly. 

Phrase: "After transplantation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: "nonfasting blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "body weights"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005910:Weights, Body [Organism Attribute]
       E   weight
  1000   C1305866:body weights [Diagnostic Procedure]
       E   weight
   861   C0043100:Weights [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   827 E C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "weekly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332174:Weekly [Temporal Concept]
Processing 00000000.tx.244: Data are expressed as meanS.E. in line graphs (n=6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.E. in line graphs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C0205132:Line [Spatial Concept]
   748   C0681493:graphs [Intellectual Product]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
   714 E C2698021:Graph [Conceptual Entity]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.245: *, p<0.05.C, 4weeks after transplantation, nonfasting plasma insulin levels were determined. 

Phrase: "*,"

Phrase: "p<0.05.C,"

Phrase: "4weeks after transplantation,"

Phrase: "nonfasting plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   890   C1276042:Plasma insulin level [Laboratory Procedure]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.246: Data are expressed as meanS.E. in bar graphs (n=6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.247: D and E, 4weeks after transplantation, islet grafts were retrieved, and mRNA levels of JNK (D) and insulin (E) in the grafts were examined by RT-PCR. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E,"

Phrase: "4weeks after transplantation,"

Phrase: "islet grafts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332835:Grafts [Tissue]
   861   C1527362:grafts [Qualitative Concept]
   827 E C0181074:{Graft} [Biomedical or Dental Material]
   827 E C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "retrieved"

Phrase: ","

Phrase: "and"

Phrase: "mRNA levels of JNK ("
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "D)"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(E) in the grafts"

Phrase: "were"

Phrase: "examined by RT-PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0332128:Examined [Finding]
   770   C0677874:pCR [Finding]
Processing 00000000.tx.248: Relative ratios of JNK/cyclophilin mRNA levels and insulin/cyclophilin mRNA levels are expressed as meanS.E. in bar graphs with those of islets infected with Ad-GFP (before transplantation) being arbitrarily set at 100(n=3). 

Phrase: "Relative ratios of JNK/cyclophilin mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "insulin/cyclophilin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0202098:insulin levels [Laboratory Procedure]
   902   C0428405:insulin levels [Laboratory or Test Result]
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: "in bar graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "with those"

Phrase: "of islets"

Phrase: "infected with Ad-GFP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   774   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "before transplantation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029216:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040732:Transplantation [Therapeutic or Preventive Procedure]
  1000   C0040733:transplantation [Functional Concept]

Phrase: ")"

Phrase: "being"

Phrase: "arbitrarily"

Phrase: "set at 100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.249: *, p<0.05.  

Phrase: "*,"

Phrase: "p<0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.250: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES It has been postulated that oxidative stress provoked under diabetic conditions is involved in -cell dysfunction characterized by decreases in insulin gene transcription and glucose-stimulated insulin secretion (29-35). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "provoked under diabetic conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0241863:DIABETIC [Finding]
   770   C1444748:Provoked [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "characterized by decreases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0547047:decreases [Quantitative Concept]
   790   C1880022:Characterized [Activity]
   756 E C0392756:Decrease [Qualitative Concept]

Phrase: "in insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "and"

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(29-35"

Phrase: ")."
Processing 00000000.tx.251: For example, ROS are produced in -cells in the diabetic state (26), and antioxidant treatment can provide some protection against this dysfunction and improve glucose tolerance (32-34). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "produced"

Phrase: "in -cells in the diabetic state"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antioxidant treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "some protection against this dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "improve"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "(32-34"

Phrase: ")."
Processing 00000000.tx.252: Thus, it is likely that oxidative stress mediates some of the toxic effects of hyperglycemia upon -cells. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "some of the toxic effects of hyperglycemia"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   748   C0205392:Some [Quantitative Concept]
   748   C0600688:toxic [Injury or Poisoning]
           Toxic effect
   748   C1280500:effects [Qualitative Concept]
   748   C1407029:Toxic [Qualitative Concept]
   748   C3540770:Some [Intellectual Product]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "upon -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.253: In this study, we examined the mechanism for oxidative stress-mediated suppression of insulin gene expression. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the mechanism for oxidative stress-mediated suppression of insulin gene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.254: We have shown that in isolated rat islets several pathways (JNK, p38 MAPK, and PKC) are activated by oxidative stress, preceding suppression of insulin gene expression (Figs. 1 and 2). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in isolated rat islets several pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]

Phrase: "(JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "are"

Phrase: "activated by oxidative stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "(Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.255: Furthermore, oxidative stress-mediated suppression of insulin gene expression and secretion was prevented by overexpression of DN-JNK (Figs. 3-5), suggesting that JNK is involved in oxidative stress-mediated suppression of insulin gene expression and secretion found in diabetes. 

Phrase: "Furthermore,"

Phrase: "oxidative stress-mediated suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "prevented by overexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514559:Overexpression [Genetic Function]
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "of DN-JNK (Figs. 3-5"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   861   C0457499:Type 5 [Intellectual Product]
   845   C0441731:Type 3 [Classification]
   818   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   795   C0205160:Negative [Qualitative Concept]
   795   C0332307:Type [Qualitative Concept]
   795   C0349966:Figs [Food]
   795   C1150587:JNK [Molecular Function]
   795   C1367731:JNK [Gene or Genome]
   795   C1513916:Negative [Finding]
   795   C1527180:Dominant [Functional Concept]
   795   C1547052:*Type [Quantitative Concept]
   795   C1705632:JNK [Gene or Genome]
   795   C2825415:Negative [Conceptual Entity]
   795   C2825491:Negative [Qualitative Concept]
   762 E C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "involved in oxidative stress-mediated suppression of insulin gene expression"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C0017262:Gene Expression [Genetic Function]
   760   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C1337112:Insulin Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0038435:Stress [Finding]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0311404:Oxidative [Functional Concept]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1314939:Involved [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "found in diabetes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.256: Suppression of insulin gene expression by JNK overexpression was accompanied by a decrease of PDX-1 DNA binding activity (Fig. 6), which may explain at least part of the suppression of insulin gene expression. 

Phrase: "Suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "was"

Phrase: "accompanied by a decrease of PDX-1 DNA binding activity"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   760   C1148673:DNA Binding [Genetic Function]
   760   C1826562:PDX-1 [Gene or Genome]
   760   C2266866:Binding Activity [Molecular Function]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205177:Activity [Functional Concept]
   739   C0243122:binding [Functional Concept]
   739   C0332134:PDX [Qualitative Concept]
   739   C0392756:Decrease [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0547047:Decrease [Quantitative Concept]
   739   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "explain at least part of the suppression of insulin gene expression."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0017262:Gene Expression [Genetic Function]
   756   C1292711:Part of [Spatial Concept]
   756   C1337112:Insulin Gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0221103:Suppression [Pathologic Function]
   738   C0301625:Suppression [Organism Function]
   738   C0439181:% suppression [Quantitative Concept]
   738   C0449719:Part [Spatial Concept]
   738   C0728721:suppression [Mental Process]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.257: PDX-1 (8-12) plays an important role in pancreas development (13-16) and differentiation (17-20) and in the regulation of cell-specific expression of insulin and various other genes essential for -cell function (21-24). 

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(8-12"

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in pancreas development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(13-16"

Phrase: ")"

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(17-20"

Phrase: ")"

Phrase: "and in the regulation of cell-specific expression of insulin"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   757   C0030281:Insulin Cell [Cell]
   739   C0007634:Cell [Cell]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205369:Specific [Qualitative Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1269647:Cell [Cell]
   739   C1327622:Regulation [Biologic Function]
   739   C1515981:And [Idea or Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1552740:specific [Intellectual Product]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "various"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "essential for -cell function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "(21-24"

Phrase: ")."
Processing 00000000.tx.258: Moreover, mutations in PDX-1 are known to cause some cases of maturity-onset diabetes of the young (57). 

Phrase: "Moreover,"

Phrase: "mutations in PDX-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "some cases of maturity-onset diabetes of the young"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.259: Thus, it is likely that JNK-mediated suppression of PDX-1 DNA binding activity accounts for some of the suppression of insulin gene transcription and of -cell function, which fits with reports that PDX-1 expression of DNA binding activity is decreased in association with reduction of insulin gene transcription after chronic exposure to a high glucose concentration (3, 4, 6, 7, 32, 33). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that JNK-mediated suppression of PDX-1 DNA binding activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]

Phrase: "accounts for some of the suppression of insulin gene transcription"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0040649:Gene Transcription [Genetic Function]
           Transcription
   760   C1337112:Insulin Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1551359:account [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C2741673:Account # [Clinical Attribute]
   739   C2981730:Account [Classification]

Phrase: "and"

Phrase: "of -cell function,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "which"

Phrase: "fits with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0036572:Fit [Sign or Symptom]
   833   C0424576:Fit [Finding]
   833   C2349186:Fit [Activity]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that PDX-1 expression of DNA binding activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased in association"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "with reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "after chronic exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205191:chronic [Temporal Concept]
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "to a high glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:high glucose [Finding]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "7,"

Phrase: "32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.260: Thus, we postulate that activation of JNK pathway leads to decreased PDX-1 activity and subsequent suppression of insulin gene transcription in the diabetic state. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "postulate"

Phrase: "that activation of JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "leads to decreased PDX-1 activity"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   790   C1826562:PDX-1 [Gene or Genome]
   783   C0086439:Decreased activity [Sign or Symptom]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0205177:Activity [Functional Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0332134:PDX [Qualitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0442797:decreased [Qualitative Concept]
   753   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "subsequent suppression of insulin gene transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "in the diabetic state."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.261: Although not examined in this study, there are several possible mechanisms for suppression of PDX-1 DNA binding activity by the JNK pathway. 

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examined in this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "are"

Phrase: "several possible mechanisms for suppression of PDX-1 DNA binding activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0441712:Mechanisms [Functional Concept]
   704 E C1706376:Mechanism [Manufactured Object]

Phrase: "by the JNK pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:JNK Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.262: One possibility is that activation of the JNK pathway influences nuclear accumulation of PDX-1, as has been shown for NFAT4, a member of the REL domain family transcription factors that are important mediators of immune response (58). 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that activation of the JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "influences"

Phrase: "nuclear accumulation of PDX-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "shown for NFAT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1417696:NFAT4 [Gene or Genome]
   790   C2985464:NFAT4 [Gene or Genome]
   756   C1547282:Show [Intellectual Product]

Phrase: "a member of the REL domain family transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "are"

Phrase: "important mediators of immune response"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   926   C0301974:MEDIATORS OF IMMUNE RESPONSE [Immunologic Factor]
   797   C0005525:Immune Mediators [Immunologic Factor,Pharmacologic Substance]
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.263: Another is that JNK activation changes the phosphorylation state of PDX-1 (59), which could influence the PDX-1 DNA binding activity. 

Phrase: "Another"

Phrase: "is"

Phrase: "that JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the phosphorylation state of PDX-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "(59"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "influence"

Phrase: "the PDX-1 DNA binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.264: As discussed later, we do not propose that suppression of insulin gene expression by oxidative stress is exclusively mediated through lowering of PDX-1; 

Phrase: "As"

Phrase: "discussed"

Phrase: "later,"

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "propose"

Phrase: "that suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "exclusively"

Phrase: "mediated through lowering of PDX-1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1826562:PDX-1 [Gene or Genome]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0332134:PDX [Qualitative Concept]
   753   C0441994:lowering [Spatial Concept]
   753   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   753   C2003888:Lowering [Activity]
   719 E C1548802:Lower [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.265: c-Jun, c-Myc, and other factors are likely to make contributions. 

Phrase: "c-Jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "c-Myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "contributions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribution [Activity]
Processing 00000000.tx.266: To examine the potential therapeutic application for islet transplantation, we transplanted DN-JNK overexpressing islets under kidney capsules of STZ diabetic nude mice and found that DN-JNK provides some protection for -cells, thus ameliorating hyperglycemia (Fig. 7). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the potential therapeutic application for islet transplantation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0185125:Application [Health Care Activity]
   748   C1947919:Application [Intellectual Product]
   748   C2347934:Application [Intellectual Product]
   748   C3539080:APPLICATION [Quantitative Concept]

Phrase: "we"

Phrase: "transplanted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040732:transplanted [Therapeutic or Preventive Procedure]
  1000   C0332835:transplanted [Tissue]
  1000   C0700106:Transplanted [Functional Concept]

Phrase: "DN-JNK overexpressing islets under kidney capsules"

Phrase: "of STZ diabetic nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025932:Mice, Nude [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C1425014:NUDE [Gene or Genome]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "some protection for -cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0524828:Cell Protection [Physiologic Function]
   770   C1545588:Protection [Finding]

Phrase: "thus"

Phrase: "ameliorating"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.267: Under hyperglycemic conditions oxidative stress is provoked in -cells (26) and some other cell types (27, 28) through processes such as the non-enzymatic glycosylation reaction (36, 37, 39, 40), the electron transport chain in mitochondria (27), and the hexosamine pathway (35). 

Phrase: "Under hyperglycemic conditions oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   812   C0311404:Oxidative [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "provoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Provoked [Qualitative Concept]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "some other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "through processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "such as the non-enzymatic glycosylation reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1511131:Enzymatic Reaction [Molecular Function]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "(36,"

Phrase: "37,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the electron transport chain in mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2244392:electron transport chain [Molecular Function]
   753   C0337112:Chain [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the hexosamine pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.268: Moreover, the JNK pathway has been found to be activated by oxidative stress (25) or high glucose (47, 48) in several cell types. 

Phrase: "Moreover,"

Phrase: "the JNK pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:JNK Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated by oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(47,"

Phrase: "48"

Phrase: ")"

Phrase: "in several cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.269: Because we used immune-deficient nude mice as recipients, we assume DN-JNK protected islet grafts from oxidative stress induced by chronic hyperglycemia. 

Phrase: "Because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immune-deficient nude mice as recipients,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025932:Mice, Nude [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1425014:NUDE [Gene or Genome]

Phrase: "we"

Phrase: "assume"

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "protected"

Phrase: "islet"

Phrase: "grafts from oxidative stress"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0181074:{Graft} [Biomedical or Dental Material]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332835:Graft [Tissue]
   770   C1527362:grafts [Qualitative Concept]
   770   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "induced by chronic hyperglycemia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0342300:Chronic hyperglycaemia [Pathologic Function]
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0205191:chronic [Temporal Concept]
   770   C0205263:Induced [Functional Concept]
Processing 00000000.tx.270: Because it has been reported that expression of c-Jun, a basic Zip transcription factor that is known to be phosphorylated by JNK, is up-regulated by oxidative stress in several cell types (60, 61) and suppresses insulin gene transcription (62, 63) by affecting the transactivation potential of the E2A gene products (64), it is possible that c-Jun expression itself is involved in suppression of insulin gene expression by oxidative stress. 

Phrase: "Because"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that expression of c-Jun,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a basic Zip transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated by JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1150587:JNK [Molecular Function]
   790   C1367731:JNK [Gene or Genome]
   790   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "up-regulated by oxidative stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]

Phrase: "in several cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "(60,"

Phrase: "61"

Phrase: ")"

Phrase: "and"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "(62,"

Phrase: "63"

Phrase: ")"

Phrase: "by affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the transactivation potential of the E2A gene products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:Potential [Qualitative Concept]

Phrase: "(64"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that c-Jun expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0162508:c-Jun [Gene or Genome]

Phrase: "itself"

Phrase: "is"

Phrase: "involved in suppression of insulin gene expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.271: Actually, as shown in Fig. 

Phrase: "Actually,"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.272: 3B, total c-Jun expression levels were moderately increased by H2O2, which should, at least in part, account for suppression of insulin gene expression by oxidative stress. 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "total c-Jun expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C3244092:expression level [Idea or Concept]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "moderately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881878:Moderately [Qualitative Concept]

Phrase: "increased by H2O2,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "which"

Phrase: "should"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "account for suppression of insulin gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]

Phrase: "by oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.273: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.274: 3, C and D, however, JNK overexpression suppressed insulin gene expression without affecting c-Jun expression levels, and DN-JNK protected insulin gene expression from oxidative stress without apparently affecting c-Jun expression levels. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "however,"

Phrase: "JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "insulin gene expression without affecting c-Jun expression levels,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0017262:Gene Expression [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   762   C0085299:jun Gene [Gene or Genome]
   762   C0162508:JUN gene [Gene or Genome]
   745   C3244092:expression level [Idea or Concept]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "protected"

Phrase: "insulin gene expression from oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   790   C1337112:Insulin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "without apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "c-Jun expression levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.275: Thus, we propose that activation of the JNK pathway is also, at least in part, involved in suppression of insulin gene expression by oxidative stress in addition to c-Jun expression. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "propose"

Phrase: "that activation of the JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "also,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "involved in suppression of insulin gene expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0017262:Gene Expression [Genetic Function]
   778   C1337112:Insulin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1314939:Involved [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "in addition to c-Jun expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0162508:c-Jun [Gene or Genome]
Processing 00000000.tx.276: However, we also suspect that c-Jun, even at low levels, is contributing to this effect. 

Phrase: "However,"

Phrase: "we also"

Phrase: "suspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750491:suspect [Idea or Concept]
  1000   C1571873:Suspect [Idea or Concept]

Phrase: "that c-Jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "even at low levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "contributing to this effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1880177:Contributing [Activity]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.277: Additionally, c-Myc, a basic helix-loop-helix-leucine zipper transcription factor, is also up-regulated by oxidative stress (60, 61) or high glucose per se (65, 66) and suppresses insulin gene expression by inhibiting NeuroD-mediated transcriptional activation (67). 

Phrase: "Additionally,"

Phrase: "c-Myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "a basic helix-loop-helix-leucine zipper transcription factor,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   869   C1515557:Basic Leucine Zipper [Amino Acid Sequence]
   835   C0282642:helix loop helix [Spatial Concept]
   812   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   793   C0018882:Helix [Eukaryote]
   793   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C0040649:Transcription [Genetic Function]
   793   C0229304:Helix [Body Part, Organ, or Organ Component]
   793   C0419518:Loop [Medical Device]
   793   C0445022:Loop [Spatial Concept]
   793   C0453984:Zipper [Manufactured Object]
   793   C1521761:Factor [Functional Concept]
   793   C1527178:Basic [Functional Concept]
   793   C1704821:Helix [Spatial Concept]
   793   C1705682:Helix [Anatomical Structure]
   793   C2827422:Factor [Conceptual Entity]
   721 E C0920750:basicity [Quantitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "up-regulated by oxidative stress"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]

Phrase: "(60,"

Phrase: "61"

Phrase: ")"

Phrase: "or"

Phrase: "high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "per se"

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")"

Phrase: "and"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "insulin gene expression by inhibiting NeuroD-mediated transcriptional activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0017262:Gene Expression [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   762   C0017255:Gene Activation [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   726   C0040649:Gene Transcription [Genetic Function]

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.278: We assume, however, that some of the suppressive effects of JNK on the insulin gene transcription are independent of c-Jun or c-Myc, because JNK activation reduces insulin gene transcription in association with suppression of PDX-1 DNA binding activity (Fig. 6), whereas both c-Jun and c-Myc suppress the insulin gene transcription through mechanisms other than PDX-1 (64, 67). 

Phrase: "We"

Phrase: "assume"

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "some of the suppressive effects of JNK"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205367:Suppressive [Functional Concept]
   748   C0205392:Some [Quantitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1280500:effects [Qualitative Concept]
   748   C1367731:JNK [Gene or Genome]
   748   C1705632:JNK [Gene or Genome]
   748   C3540770:Some [Intellectual Product]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "are independent of c-Jun"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332291:Independent of [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1551058:Are [Quantitative Concept]
   760   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "c-Myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "because"

Phrase: "JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "reduces"

Phrase: "insulin gene transcription in association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "with suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of PDX-1 DNA binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "both c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "c-Myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the insulin gene transcription through mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "other than PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(64,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.279: Although JNK activation by oxidative stress preceded suppression of insulin gene expression (Fig. 2, A and D), there was some difference in timing between activation of JNK and suppression of insulin gene expression. 

Phrase: "Although"

Phrase: "JNK activation by oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "suppression of insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "some difference in timing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "suppression of insulin gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]
Processing 00000000.tx.280: We think this is due to stability of insulin mRNA (about 24-48 h) (68); 

Phrase: "We"

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: "this"

Phrase: "is due to stability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0205360:Stability [Qualitative Concept]
   770   C2347098:Stability [Qualitative Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "of insulin mRNA (about 24-48 h) (68"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0033727:H+ [Element, Ion, or Isotope]
   795   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441932:H+ [Classification]
   795   C0450387:68 [Intellectual Product]
   795   C0564385:/h [Quantitative Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.281: even if insulin gene transcription is completely suppressed, insulin mRNA levels should not fall very quickly. 

Phrase: "even"

Phrase: "if"

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: ","

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085639:Fall [Finding]
  1000   C0238715:Fall [Temporal Concept]

Phrase: "very quickly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]
Processing 00000000.tx.282: Also, although WT-JNK suppressed insulin gene expression and DN-JNK protected some of the reduction of insulin gene expression from oxidative stress (Fig. 3D), the extent of insulin gene expression was not completely correlated with phosphorylated c-Jun levels, which is regulated by JNK pathway. 

Phrase: "Also,"

Phrase: "although"

Phrase: "WT-JNK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1150587:JNK [Molecular Function]
   827   C1367731:JNK [Gene or Genome]
   827   C1705632:JNK [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "protected"

Phrase: "some of the reduction of insulin gene expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0017262:Gene Expression [Genetic Function]
   770   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205392:Some [Quantitative Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3540770:Some [Intellectual Product]

Phrase: "from oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "the extent of insulin gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "correlated with phosphorylated c-Jun levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0441889:Levels [Qualitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "regulated by JNK pathway."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1621396:JNK Pathway [Molecular Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1704259:Pathway [Molecular Function]
   770   C1705632:JNK [Gene or Genome]
   770   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.283: Whereas insulin gene expression was clearly decreased by H2O2 treatment alone or Ad-WT-JNK overexpression alone, expression levels of total and phosphorylated c-Jun were only slightly induced by these treatments (Fig. 3, C and D). 

Phrase: "Whereas"

Phrase: "insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "clearly"

Phrase: "decreased by H2O2 treatment"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "Ad-WT-JNK overexpression alone, expression levels of total"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0441889:Levels [Qualitative Concept]
   726   C3244092:expression level [Idea or Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "induced by these treatments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0205263:Induced [Functional Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.284: We think this may be due to very low expression levels of c-Jun in islets; 

Phrase: "We"

Phrase: "think"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:think [Mental Process]

Phrase: "this"

Phrase: "may"

Phrase: "be due to very low expression levels of c-Jun"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   760   C0442811:Very low [Finding]
   760   C0678226:Due to [Functional Concept]
           due
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205251:low [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0442824:Very [Qualitative Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1550472:low [Idea or Concept]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]
   739   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C3244092:expression level [Idea or Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in islets"

Phrase: ";"
Processing 00000000.tx.285: c-Jun expression in islets is quite low, and thus H2O2 treatment alone or Ad-WT-JNK overexpression alone was not enough to induce clear bands of phosphorylated c-Jun. 

Phrase: "c-Jun expression in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "quite low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "thus H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "Ad-WT-JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1514559:Overexpression [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "not enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "clear bands of phosphorylated c-Jun."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]
Processing 00000000.tx.286: Also, although phosphorylated c-Jun expression was markedly induced by H2O2 in the presence of WT-JNK, the extent of decrease in insulin gene expression was similar to that after H2O2 treatment alone or Ad-WT-JNK overexpression alone. 

Phrase: "Also,"

Phrase: "although"

Phrase: "phosphorylated c-Jun expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "induced by H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of WT-JNK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1150587:JNK [Molecular Function]
   827   C1367731:JNK [Gene or Genome]
   827   C1705632:JNK [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "the extent of decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "in insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "after H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "Ad-WT-JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1514559:Overexpression [Genetic Function]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.287: This may also be due to stability of insulin mRNA (half-life is 24-48 h) (68); 

Phrase: "This"

Phrase: "may"

Phrase: "also"

Phrase: "be due to stability of insulin mRNA (half-life"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0018517:Half-Life [Temporal Concept]
   764   C0678226:Due to [Functional Concept]
           due
   762   C1257757:mRNA Stability [Qualitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205360:Stability [Qualitative Concept]
   742   C0376558:Life [Idea or Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2347098:Stability [Qualitative Concept]
   742   C2825407:Half [Quantitative Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]

Phrase: "is"

Phrase: "24-48 h) (68"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0450387:68 [Intellectual Product]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.288: even if insulin gene transcription is strongly suppressed, insulin mRNA levels should not be markedly decreased in 48h. 

Phrase: "even"

Phrase: "if"

Phrase: "insulin gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "is"

Phrase: "strongly"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: ","

Phrase: "insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "decreased in 48h."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C1442464:48H [Temporal Concept]
   756 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.289: Thus, we assume that because H2O2 treatment alone or Ad-WT-JNK alone exerts maximal suppressive effects on insulin gene transcription, the combination of H2O2 and WT-JNK overexpression would not be expected to show additional effects (Fig. 3C). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "assume"

Phrase: "that"

Phrase: "because"

Phrase: "H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "Ad-WT-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "maximal suppressive effects on insulin gene transcription,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "the combination of H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "WT-JNK overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "additional effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.290: It has been reported that -cell destruction by cytokines such as interleukin-1 (69-73) can be prevented by inhibition of the JNK pathway (74-77), implying that JNK plays a role in autoimmune -cell destruction. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -cell destruction by cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261381:Destruction [Therapeutic or Preventive Procedure]
   760   C1948029:Destruction [Activity]

Phrase: "such as interleukin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(69-73"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "prevented by inhibition of the JNK pathway"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1621396:JNK Pathway [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1704259:Pathway [Molecular Function]
   748   C1705632:JNK [Gene or Genome]
   748   C1705987:Pathway [Conceptual Entity]
   748   C3463820:Inhibition [Activity]
   714   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(74-77"

Phrase: ")"

Phrase: ","

Phrase: "implying"

Phrase: "that JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in autoimmune -cell destruction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.291: It should be noted, however, because in this study we used immune-deficient nude mice as recipients, it is not likely that DN-JNK protected islet grafts from oxidative stress induced by immune reaction, although we cannot totally exclude the possibility that DN-JNK exerted some beneficial effects on less obvious oxidative injury induced during the transplantation operation. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "however,"

Phrase: "because in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immune-deficient nude mice as recipients,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025932:Mice, Nude [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1425014:NUDE [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "not likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "that DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "protected"

Phrase: "islet"

Phrase: "grafts from oxidative stress"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0181074:{Graft} [Biomedical or Dental Material]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332835:Graft [Tissue]
   770   C1527362:grafts [Qualitative Concept]
   770   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]

Phrase: "induced by immune reaction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205263:Induced [Functional Concept]
   770   C0439662:Immune [Functional Concept]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "totally"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that DN-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "some beneficial effects on less obvious oxidative injury"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "induced during the transplantation operation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   760   C0040733:transplantation [Functional Concept]
   760   C0205263:Induced [Functional Concept]
   760   C0543467:Operation [Health Care Activity]
   760   C3241922:Operation [Activity]
Processing 00000000.tx.292: It has been reported that under hyperglycemic conditions production of ROS is increased in -cells (26) and some other cell types (27, 28) and that levels of 8-hydroxy-2'-deoxyguanosine, a marker for oxidative stress, are increased in the blood of type 2diabetic patients (41, 42). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that under hyperglycemic conditions production of ROS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0033268:production [Occupational Activity]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1705920:Species [Conceptual Entity]
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "some other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "and"

Phrase: "that levels of 8-hydroxy-2'-deoxyguanosine,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "a marker for oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "increased in the blood of type 2diabetic patients"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0005810:blood type [Classification]
   767   C1383165:Blood Type [Clinical Attribute]
   767   C3274467:Blood Type [Diagnostic Procedure]
   750   C1550335:Patient type [Classification]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205217:Increased [Quantitative Concept]
   744   C0229664:Blood [Body Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.293: Also, as shown in this study, JNK is activated by oxidative stress in islets, and the JNK activation reduces the PDX-1 DNA binding activity and insulin gene transcription. 

Phrase: "Also,"

Phrase: "as"

Phrase: "shown in this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "activated by oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "in islets,"

Phrase: "and"

Phrase: "the JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "reduces"

Phrase: "the PDX-1 DNA binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin gene transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1337112:Insulin Gene [Gene or Genome]
Processing 00000000.tx.294: Thus, we assume that JNK is involved in deterioration of -cell function in both type 2diabetes and the early stages of type 1diabetes. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "assume"

Phrase: "that JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "is"

Phrase: "involved in deterioration of -cell function"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007613:Cell Function [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C0868945:Deterioration [Phenomenon or Process]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1705273:Function [Intellectual Product]
   753   C1948049:Cell [Spatial Concept]

Phrase: "in both type 2diabetes"

Phrase: "and"

Phrase: "the early stages of type 1diabetes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C2363430:early stages [Temporal Concept]
   773 E C1517886:Early Stage [Classification]
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.295: In conclusion, the present results provide new insights into the mechanism through which oxidative stress suppresses insulin gene transcription in pancreatic -cells, and the finding that this adverse outcome can be prevented by DN-JNK overexpression suggests that the JNK pathway in -cells could become a new therapeutic target for diabetes.  

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new insights into the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]

Phrase: "through which oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "insulin gene transcription in pancreatic -cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "and"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "this adverse outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1274040:Outcome [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by DN-JNK overexpression"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   748   C0205160:Negative [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1150587:JNK [Molecular Function]
   748   C1367731:JNK [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1514559:Overexpression [Genetic Function]
   748   C1527180:Dominant [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705632:JNK [Gene or Genome]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   714   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the JNK pathway in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "become"

Phrase: "a new therapeutic target for diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.296: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.297: Bert Vogelstein (The Johns Hopkins Oncology Center) for kindly providing the AdEasy system, Dr. 

Phrase: "Bert Vogelstein"

Phrase: "("

Phrase: "The Johns Hopkins Oncology Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the AdEasy system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.298: Yoshitaka Kajimoto (Osaka University School of Medicine) for the PDX-1 antibody, and Dr. 

Phrase: "Yoshitaka Kajimoto"

Phrase: "(Osaka University School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for the PDX-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.299: Hitoshi Miyazaki (Gene Experiment Center, University of Tsukuba, Japan) for helpful suggestions. 

Phrase: "Hitoshi Miyazaki"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0315755:Miyazaki [Bacterium]

Phrase: "(Gene Experiment Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "University of Tsukuba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "for helpful suggestions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038659:Suggestions [Idea or Concept]
   827 E C1705535:suggestion [Idea or Concept]
Processing 00000000.tx.300: We also thank the RIA Core Laboratory of the Diabetes and Endocrinology Research Center of the Joslin Diabetes Center for the insulin radioimmunoassays.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the RIA Core Laboratory of the Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0022877:Laboratory [Manufactured Object,Organization]
   748   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "Endocrinology Research Center of the Joslin Diabetes Center"

Phrase: "for the insulin radioimmunoassays."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034580:Radioimmunoassays [Laboratory Procedure]
Processing 00000000.tx.301: FOOTNOTES * This work was supported in part by National Institutes of Health Grant DK-35449, by Diabetes and Endocrinology Research Center Grant DK-36836 of the Joslin Diabetes Center which allowed use of the RIA Core, Animal Core, and Media Core, the Diabetes Research and Wellness Foundation, and by an important group of private donors.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health Grant DK-35449,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   877   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   795   C0011318:DK [Geographic Area]
   795   C0018173:Grant [Quantitative Concept]
   795   C0018684:Health [Idea or Concept]
   795   C0021622:Institutes [Organization]
   795   C1548284:Grant [Idea or Concept]
   795   C3245503:national [Intellectual Product]
   762 E C1272753:Institute [Idea or Concept]

Phrase: "by Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Endocrinology Research Center Grant DK-36836 of the Joslin Diabetes Center"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0683939:research center [Manufactured Object,Organization]
   754   C0260206:research grant [Research Activity]
   738   C0011318:DK [Geographic Area]
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   738   C0018173:Grant [Quantitative Concept]
   738   C0035168:research [Research Activity]
   738   C0205099:Center [Spatial Concept]
   738   C0242481:Research [Research Activity]
   738   C1548284:Grant [Idea or Concept]

Phrase: "which"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "use of the RIA Core,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "Animal Core,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "and"

Phrase: "Media Core,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]

Phrase: "the Diabetes Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Wellness Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "and by an important group of private donors."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0013018:Donors [Population Group]
   744   C0441833:Group [Idea or Concept]
   744   C0679727:Private [Organization]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1515981:And [Idea or Concept]
   744   C1527169:Donors [Finding]
   744   C1552516:Group [Health Care Related Organization]
   744   C1553444:Private [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   711 E C0040288:Donor [Population Group]
Processing 00000000.tx.302: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.303: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.304: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.305: Recipient of a fellowship and grant from the Japan Society for the Promotion of Science. 

Phrase: "Recipient of a fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709854:Recipient [Human]

Phrase: "and"

Phrase: "grant from the Japan Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018173:Grant [Quantitative Concept]
   760   C1548284:Grant [Idea or Concept]

Phrase: "for the Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.306: To whom correspondence may be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.307: E-mail: kaneto@osb.att.ne.jp. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kaneto@osb.att.ne.jp."
Processing 00000000.tx.308: ** To whom correspondence may be addressed: Section on Islet Transplantation and Cell Biology, Joslin Diabetes Center, Boston, MA 02215.Tel.: 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Section on Islet Transplantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205155:Section [Spatial Concept]
   770   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   770   C1522472:Section [Substance]
   770   C1552923:Section [Quantitative Concept]
   770   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02215.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.309: 617-732-2581; 

Phrase: "617-732-2581"

Phrase: ";"
Processing 00000000.tx.310: Fax: 617-732-2650,E-mail: gordon.weir@joslin.harvard.edu or kaneto@osb.att.ne.jp. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-732-2650,"

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gordon.weir@joslin.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "kaneto@osb.att.ne.jp."
Processing 00000000.tx.311: Published, JBC Papers in Press, May 14,2002,DOI 10.1074/jbc.M202066200  ABBREVIATIONS The abbreviations used are: PDX-1, pancreatic and duodenal homeobox factor-1; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "May 14,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M202066200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "duodenal homeobox factor-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.312: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.313: JNK, c-Jun N-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.314: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.315: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.316: WT, wild type; 

Phrase: "WT, wild type"

Phrase: ";"
Processing 00000000.tx.317: DN, dominant-negative type; 

Phrase: "DN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "dominant-negative type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.318: GFP, green fluorescent protein; 

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.319: pfu, plaque-forming unit; 

Phrase: "pfu,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]
   827   C0011389:Plaque [Disease or Syndrome]
   827   C0205431:Forming [Functional Concept]
   827   C0332461:Plaque [Finding]
   827   C0333463:plaque [Acquired Abnormality]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   827   C1522492:Forming [Functional Concept]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "plaque-forming unit"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1882406:Plaque Forming Unit [Quantitative Concept]
   827   C0011389:Plaque [Disease or Syndrome]
   827   C0205431:Forming [Functional Concept]
   827   C0332461:Plaque [Finding]
   827   C0333463:plaque [Acquired Abnormality]
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1522492:Forming [Functional Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.320: STZ, streptozotocin; 

Phrase: "STZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ";"
Processing 00000000.tx.321: NAC, N-acetyl-L-cysteine; 

Phrase: "NAC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538756:NAC [Gene or Genome]

Phrase: "N-acetyl-L-cysteine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ";"
Processing 00000000.tx.322: Ad, adenovirus.  

Phrase: "Ad,"

Phrase: "adenovirus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.323: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.324: Weir, G. 

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.325: C., Laybutt, D. 

Phrase: "C., Laybutt,"

Phrase: "D."
Processing 00000000.tx.326: R., Kaneto, H., Bonner-Weir, S., and Sharma, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sharma,"

Phrase: "A."
Processing 00000000.tx.327: (2001) Diabetes 50, S154-159[Free FullText] 2. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "S154-159"

Phrase: "[Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.328: Bonner-Weir, S., Trent, D. 

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Trent,"

Phrase: "D."
Processing 00000000.tx.329: F., and Weir, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.330: C. 

Phrase: "C."
Processing 00000000.tx.331: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.332: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.333: Invest. 

Phrase: "Invest."
Processing 00000000.tx.334: 71, 1544-1553[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "1544-1553"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.335: Sharma, A., Olson, L. 

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.336: K., Robertson, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.337: P., and Stein, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.339: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.340: 9, 1127-1134[Abstract] 4. 

Phrase: "9,"

Phrase: "1127-1134"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4."
Processing 00000000.tx.341: Olson, L. 

Phrase: "Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.342: K., Sharma, A., Peshavaria, M., Wright, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "Peshavaria,"

Phrase: "M."

Phrase: ","

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C."
Processing 00000000.tx.343: V.E., Towle, H. 

Phrase: "V.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231963:V E [Laboratory or Test Result]

Phrase: "Towle,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.344: C., Robertson, R. 

Phrase: "C., Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.345: P., and Stein, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.347: Natl. 

Phrase: "Natl."
Processing 00000000.tx.348: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.349: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.350: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.351: 92, 514-519 5. 

Phrase: "92,"

Phrase: "514-519 5."
Processing 00000000.tx.352: Tokuyama, Y., Sturis, J., DePaoli, A. 

Phrase: "Tokuyama,"

Phrase: "Y.,"

Phrase: "Sturis,"

Phrase: "J.,"

Phrase: "DePaoli,"

Phrase: "A."
Processing 00000000.tx.353: M., Takeda, J., Stoffel, M., Tang, J., Sun, X., Polonsky, K. 

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "J.,"

Phrase: "Stoffel,"

Phrase: "M."

Phrase: ","

Phrase: "Tang,"

Phrase: "J.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Polonsky,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.354: S., and Bell, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.355: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.356: (1995) Diabetes 44, 1447-1457[Abstract] 6. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Diabetes 44,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1447-1457"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 6."
Processing 00000000.tx.357: Zangen, D. 

Phrase: "Zangen,"

Phrase: "D."
Processing 00000000.tx.358: H., Bonner-Weir, S., Lee, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Lee,"

Phrase: "C."
Processing 00000000.tx.359: H., Latimer, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Latimer,"

Phrase: "J."
Processing 00000000.tx.360: B., Miller, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.361: P., Habener, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.362: F., and Weir, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.363: C. 

Phrase: "C."
Processing 00000000.tx.364: (1997) Diabetes 46, 258-264[Abstract] 7. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetes 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "258-264"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 7."
Processing 00000000.tx.365: Jonas, J.-C., Sharma, A., Hasenkamp, W., Iikova, H., Patane, G., Laybutt, R., Bonner-Weir, S., and Weir, G. 

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "J.-C., Sharma,"

Phrase: "A.,"

Phrase: "Hasenkamp,"

Phrase: "W.,"

Phrase: "Iikova,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Patane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445184:Patane [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Laybutt,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.366: C. 

Phrase: "C."
Processing 00000000.tx.367: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Biol. 

Phrase: "Biol."
Processing 00000000.tx.369: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.370: 274, 14112-14121[Abstract/Free FullText] 8. 

Phrase: "274,"

Phrase: "14112-14121"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.371: Ohlsson, H., Karlsson, K., and Edlund, T. 

Phrase: "Ohlsson,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Karlsson,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Edlund,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: (1993) EMBO J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.373: 12, 4251-4259[Abstract] 9. 

Phrase: "12,"

Phrase: "4251-4259"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 9."
Processing 00000000.tx.374: Leonard, J., Peers, B., Johnson, T., Ferreri, K., Lee, S., and Montminy, M. 

Phrase: "Leonard,"

Phrase: "J.,"

Phrase: "Peers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679739:peers [Population Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ferreri,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.376: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.377: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.378: 7, 1275-1283[Abstract] 10. 

Phrase: "7,"

Phrase: "1275-1283"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10."
Processing 00000000.tx.379: Miller, C. 

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.380: P., McGehee, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McGehee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.381: E., and Habener, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.382: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.383: (1994) EMBO J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.384: 13, 1145-1156[Abstract] 11. 

Phrase: "13,"

Phrase: "1145-1156"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.385: Stoffers, D. 

Phrase: "Stoffers,"

Phrase: "D."
Processing 00000000.tx.386: A., Thomas, M. 

Phrase: "A.,"

Phrase: "Thomas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: K., and Habener, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.388: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.389: (1997) Trends Endocrinol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol."
Processing 00000000.tx.390: Metab. 

Phrase: "Metab."
Processing 00000000.tx.391: 8, 145-151[CrossRef] 12. 

Phrase: "8,"

Phrase: "145-151"

Phrase: "[CrossRef"

Phrase: "] 12."
Processing 00000000.tx.392: Weir, G. 

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.393: C., Sharma, A., Zangen, D. 

Phrase: "C., Sharma,"

Phrase: "A.,"

Phrase: "Zangen,"

Phrase: "D."
Processing 00000000.tx.394: H., and Bonner-Weir, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bonner-Weir,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: (1997) Acta Diabetol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Acta Diabetol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0701230:Diabetol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.396: 34, 177-184[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "34,"

Phrase: "177-184"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.397: Jonsson, J., Carlsson, L., Edlund, T., and Edlund, H. 

Phrase: "Jonsson,"

Phrase: "J.,"

Phrase: "Carlsson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Edlund,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Edlund,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.398: (1994) Nature 37, 606-609 14. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 37,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "606-609 14."
Processing 00000000.tx.399: Ahlgren, U., Jonsson, J., and Edlund, H. 

Phrase: "Ahlgren,"

Phrase: "U.,"

Phrase: "Jonsson,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Edlund,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.400: (1996) Development 122, 1409-1416[Abstract/Free FullText] 15. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Development 122,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "1409-1416"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.401: Offield, M. 

Phrase: "Offield,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: F., Jetton, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jetton,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.403: L., Labosky, P., Ray, M., Stein, R., Magnuson, M., Hogan, B. 

Phrase: "L., Labosky,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Stein,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Magnuson,"

Phrase: "M."

Phrase: ","

Phrase: "Hogan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.404: L.M., and Wright, C. 

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C."
Processing 00000000.tx.405: V.E. 

Phrase: "V.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231963:V E [Laboratory or Test Result]
Processing 00000000.tx.406: (1996) Development 122, 983-985[Abstract/Free FullText] 16. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Development 122,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "983-985"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.407: Kaneto, H., Miyagawa, J., Kajimoto, Y., Yamamoto, K., Watada, H., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., Higashiyama, S., and Taniguchi, N. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyagawa,"

Phrase: "J.,"

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Watada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Umayahara,"

Phrase: "Y.,"

Phrase: "Hanafusa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuzawa,"

Phrase: "Y.,"

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "Higashiyama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.408: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.409: Biol. 

Phrase: "Biol."
Processing 00000000.tx.410: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.411: 272, 29137-29143[Abstract/Free FullText] 17. 

Phrase: "272,"

Phrase: "29137-29143"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.412: Sharma, A., Zangen, D. 

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "Zangen,"

Phrase: "D."
Processing 00000000.tx.413: H., Reitz, P., Taneja, M., Lissauer, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Reitz,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Taneja,"

Phrase: "M."

Phrase: ","

Phrase: "Lissauer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.414: E., Miller, C. 

Phrase: "E.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.415: P., Weir, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.416: C., Habener, J. 

Phrase: "C., Habener,"

Phrase: "J."
Processing 00000000.tx.417: F., and Bonner-Weir, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Bonner-Weir,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.418: (1999) Diabetes 48, 507-513[Abstract] 18. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "507-513"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 18."
Processing 00000000.tx.419: Bonner-Weir, S., Taneja, M., Weir, G. 

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Taneja,"

Phrase: "M."

Phrase: ","

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.420: C., Tatarkiewicz, K., Song, K.-H., Sharma, A., and O'Neil, J. 

Phrase: "C., Tatarkiewicz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "and"

Phrase: "O'Neil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.421: J. 

Phrase: "J."
Processing 00000000.tx.422: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.423: Natl. 

Phrase: "Natl."
Processing 00000000.tx.424: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.425: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.426: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.427: 97, 7999-8004[Abstract/Free FullText] 19. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "7999-8004"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.428: Watada, H., Kajimoto, Y., Miyagawa, J., Hanafusa, T., Hamaguchi, K., Matsuoka, T., Yamamoto, K., Matsuzawa, Y., Kawamori, R., and Yamasaki, Y. 

Phrase: "Watada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Miyagawa,"

Phrase: "J.,"

Phrase: "Hanafusa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hamaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "Y.,"

Phrase: "Kawamori,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Yamasaki,"

Phrase: "Y."
Processing 00000000.tx.429: (1996) Diabetes 45, 1826-1831[Abstract] 20. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1826-1831"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20."
Processing 00000000.tx.430: Serup, P., Jensen, J., Andersen, F. 

Phrase: "Serup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jensen,"

Phrase: "J.,"

Phrase: "Andersen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.431: G., Jorgensen, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jorgensen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.432: C., Blume, N., Holst, J. 

Phrase: "C., Blume,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Holst,"

Phrase: "J."
Processing 00000000.tx.433: J., and Madsen, O. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Madsen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.434: D. 

Phrase: "D."
Processing 00000000.tx.435: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.436: Natl. 

Phrase: "Natl."
Processing 00000000.tx.437: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.438: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.439: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.440: 93, 9015-9020[Abstract/Free FullText] 21. 

Phrase: "93,"

Phrase: "9015-9020"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.441: Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., and Edlund, H. 

Phrase: "Ahlgren,"

Phrase: "U.,"

Phrase: "Jonsson,"

Phrase: "J.,"

Phrase: "Jonsson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Simu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Edlund,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.442: (1998) Genes Dev. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.443: 12, 1763-1768[Abstract/Free FullText] 22. 

Phrase: "12,"

Phrase: "1763-1768"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.444: Wang, H., Maechler, P., Ritz-Laser, B., Hagenfeldt, K. 

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ritz-Laser,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023089:Laser [Manufactured Object]
   861   C0458142:Laser [Phenomenon or Process]
   861   C1023865:Laser [Plant]
   861   C1706315:Laser [Medical Device]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hagenfeldt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.445: A., Ishihara, H., Philippe, J., and Wollheim, C. 

Phrase: "A.,"

Phrase: "Ishihara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Philippe,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.446: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.447: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: 276, 25279-25286[Abstract/Free FullText] 23. 

Phrase: "276,"

Phrase: "25279-25286"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.451: Waeber, G., Thompson, N., Nicod, P., and Bonny, C. 

Phrase: "Waeber,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thompson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nicod,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Bonny,"

Phrase: "C."
Processing 00000000.tx.452: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.453: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.454: 10, 1327-1334[Abstract] 24. 

Phrase: "10,"

Phrase: "1327-1334"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.455: Watada, H., Kajimoto, Y., Umayahara, Y., Matsuoka, T., Kaneto, H., Fujitani, Y., Kamada, T., Kawamori, R., and Yamasaki, Y. 

Phrase: "Watada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Umayahara,"

Phrase: "Y.,"

Phrase: "Matsuoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujitani,"

Phrase: "Y.,"

Phrase: "Kamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kawamori,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Yamasaki,"

Phrase: "Y."
Processing 00000000.tx.456: (1996) Diabetes 45, 1478-1488[Abstract] 25. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1478-1488"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25."
Processing 00000000.tx.457: Finkel, T., and Holbrook, N. 

Phrase: "Finkel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Holbrook,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.458: J. 

Phrase: "J."
Processing 00000000.tx.459: (2000) Nature 408, 239-247[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "239-247"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.460: Ihara, Y., Toyokuni, S., Uchida, K., Odaka, H., Tanaka, T., Ikeda, H., Hiai, H., Seino, Y., and Yamada, Y. 

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "Toyokuni,"

Phrase: "S."

Phrase: ","

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Odaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hiai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Yamada,"

Phrase: "Y."
Processing 00000000.tx.461: (1999) Diabetes 48, 927-932[Abstract] 27. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "927-932"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 27."
Processing 00000000.tx.462: Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. 

Phrase: "Nishikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Edelstein,"

Phrase: "D."

Phrase: ","

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "X.L., Yamagishi,"

Phrase: "S."

Phrase: ","

Phrase: "Matsumura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kaneda,"

Phrase: "Y.,"

Phrase: "Yorek,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.463: A., Beebe, D., Oates, P. 

Phrase: "A.,"

Phrase: "Beebe,"

Phrase: "D."

Phrase: ","

Phrase: "Oates,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.464: J., Hammes, H.-P., Giardino, I., and Brownlee, M. 

Phrase: "J.,"

Phrase: "Hammes,"

Phrase: "H.-P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Giardino,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Brownlee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.465: (2000) Nature 404, 787-790[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 404,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "787-790"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.466: Laybutt, D. 

Phrase: "Laybutt,"

Phrase: "D."
Processing 00000000.tx.467: R., Kaneto, H., Hasenkamp, W., Grey, S., Jonas, J.-C., Sgroi, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hasenkamp,"

Phrase: "W.,"

Phrase: "Grey,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "J.-C., Sgroi,"

Phrase: "D."
Processing 00000000.tx.468: C., Groff, A., Ferran, C., Bonner-Weir, S., Sharma, A., and Weir, G. 

Phrase: "C., Groff,"

Phrase: "A.,"

Phrase: "Ferran,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.469: C. 

Phrase: "C."
Processing 00000000.tx.470: (2002) Diabetes 51, 413-423[Abstract/Free FullText] 29. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetes 51,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "413-423"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.471: Kaneto, H., Fujii, J., Myint, T., Miyazawa, N., Islam, K. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujii,"

Phrase: "J.,"

Phrase: "Myint,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Miyazawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Islam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022126:Islam [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.472: N., Kawasaki, Y., Suzuki, K., Nakamura, M., Tatsumi, H., Yamasaki, Y., and Taniguchi, N. 

Phrase: "N., Kawasaki,"

Phrase: "Y.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "M."

Phrase: ","

Phrase: "Tatsumi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.473: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.474: J. 

Phrase: "J."
Processing 00000000.tx.475: 320, 855-863[Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "320,"

Phrase: "855-863"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.476: Matsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R., and Yamasaki, Y. 

Phrase: "Matsuoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Watada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kishimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Umayahara,"

Phrase: "Y.,"

Phrase: "Fujitani,"

Phrase: "Y.,"

Phrase: "Kamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kawamori,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Yamasaki,"

Phrase: "Y."
Processing 00000000.tx.477: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.478: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.479: Invest. 

Phrase: "Invest."
Processing 00000000.tx.480: 99, 144-150[Abstract/Free FullText] 31. 

Phrase: "99,"

Phrase: "144-150"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.481: Maechler, P., Jornot, L., and Wollheim, C. 

Phrase: "Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jornot,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wollheim,"

Phrase: "C."
Processing 00000000.tx.482: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.483: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.484: Biol. 

Phrase: "Biol."
Processing 00000000.tx.485: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.486: 274, 27905-27913[Abstract/Free FullText] 32. 

Phrase: "274,"

Phrase: "27905-27913"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.487: Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., and Hori, M. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Miyagawa,"

Phrase: "J.,"

Phrase: "Matsuoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujitani,"

Phrase: "Y.,"

Phrase: "Umayahara,"

Phrase: "Y.,"

Phrase: "Hanafusa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuzawa,"

Phrase: "Y.,"

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Hori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: (1999) Diabetes 48, 2398-2406[Abstract] 33. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "2398-2406"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 33."
Processing 00000000.tx.489: Tanaka, Y., Gleason, C. 

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "Gleason,"

Phrase: "C."
Processing 00000000.tx.490: E., Tran, P. 

Phrase: "E.,"

Phrase: "Tran,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.491: O.T., Harmon, J. 

Phrase: "O.T.,"

Phrase: "Harmon,"

Phrase: "J."
Processing 00000000.tx.492: S., and Robertson, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.494: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.495: Natl. 

Phrase: "Natl."
Processing 00000000.tx.496: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.497: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.498: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.499: 96, 10857-10862[Abstract/Free FullText] 34. 

Phrase: "96,"

Phrase: "10857-10862"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.500: Ihara, Y., Yamada, Y., Toyokuni, S., Miyawaki, K., Ban, N., Adachi, T., Kuroe, A., Iwakura, T., Kubota, A., Hiai, H., and Seino, Y. 

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "Yamada,"

Phrase: "Y.,"

Phrase: "Toyokuni,"

Phrase: "S."

Phrase: ","

Phrase: "Miyawaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ban,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683610:ban [Social Behavior]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Adachi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kuroe,"

Phrase: "A.,"

Phrase: "Iwakura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kubota,"

Phrase: "A.,"

Phrase: "Hiai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Seino,"

Phrase: "Y."
Processing 00000000.tx.501: (2000) FEBS Lett. 

Phrase: "(2000"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.502: 473, 24-26[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "473,"

Phrase: "24-26"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.503: Kaneto, H., Xu, G., Song, K.-H., Suzuma, K., Bonner-Weir, S., Sharma, A., and Weir, G. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Xu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Suzuma,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.504: C. 

Phrase: "C."
Processing 00000000.tx.505: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.506: Biol. 

Phrase: "Biol."
Processing 00000000.tx.507: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.508: 276, 31099-31104[Abstract/Free FullText] 36. 

Phrase: "276,"

Phrase: "31099-31104"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.509: Baynes, J. 

Phrase: "Baynes,"

Phrase: "J."
Processing 00000000.tx.510: W. 

Phrase: "W."
Processing 00000000.tx.511: (1991) Diabetes 40, 405-412[Abstract] 37. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Diabetes 40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: "405-412"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37."
Processing 00000000.tx.512: Baynes, J. 

Phrase: "Baynes,"

Phrase: "J."
Processing 00000000.tx.513: W., and Thorpe, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Thorpe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: (1999) Diabetes 48, 1-9[Abstract] 38. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 38."
Processing 00000000.tx.516: Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. 

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "X.-L., Edelstein,"

Phrase: "D."

Phrase: ","

Phrase: "Rossetti,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fantus,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.517: G., Goldberg, H., Ziyadeh, F., Wu, J., and Brownlee, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldberg,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ziyadeh,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J.,"

Phrase: "and"

Phrase: "Brownlee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.519: Natl. 

Phrase: "Natl."
Processing 00000000.tx.520: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.521: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.522: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.523: 97, 12222-12226[Abstract/Free FullText] 39. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "12222-12226"

Phrase: "[Abstract/Free FullText"

Phrase: "] 39."
Processing 00000000.tx.524: Sakurai, T., and Tsuchiya, S. 

Phrase: "Sakurai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tsuchiya,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.525: (1988) FEBS Lett. 

Phrase: "(1988"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.526: 236, 406-410[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "236,"

Phrase: "406-410"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.527: Ookawara, T., Kawamura, N., Kitagawa, Y., and Taniguchi, N (1992) J. 

Phrase: "Ookawara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kawamura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kitagawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "N (1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.528: Biol. 

Phrase: "Biol."
Processing 00000000.tx.529: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.530: 267, 18505-18510[Abstract/Free FullText] 41. 

Phrase: "267,"

Phrase: "18505-18510"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.531: Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., and Nicotera, T. 

Phrase: "Dandona,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Thusu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Snyder,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Makowski,"

Phrase: "J.,"

Phrase: "Armstrong,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Nicotera,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.532: (1996) Lancet 347, 444-445[CrossRef][Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Lancet 347,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "444-445"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.533: Leinonen, J., Lehtimaki, T., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Laippala, P., Rantalaiho, V., Wirta, O., Pasternack, A., and Alho, H. 

Phrase: "Leinonen,"

Phrase: "J.,"

Phrase: "Lehtimaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Toyokuni,"

Phrase: "S."

Phrase: ","

Phrase: "Okada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hiai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ochi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Laippala,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rantalaiho,"

Phrase: "V.,"

Phrase: "Wirta,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Pasternack,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Alho,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.534: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.535: 417, 150-152[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "417,"

Phrase: "150-152"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.536: Tiedge, M., Lortz, S., Drinkgern, J., and Lenzen, S. 

Phrase: "Tiedge,"

Phrase: "M."

Phrase: ","

Phrase: "Lortz,"

Phrase: "S."

Phrase: ","

Phrase: "Drinkgern,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Lenzen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.537: (1997) Diabetes 46, 1733-1742[Abstract] 44. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetes 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1733-1742"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 44."
Processing 00000000.tx.538: Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. 

Phrase: "Hibi,"

Phrase: "M."

Phrase: ","

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "A.,"

Phrase: "Smeal,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Minden,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.539: (1993) Genes Dev. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.540: 7, 2135-2148[Abstract] 45. 

Phrase: "7,"

Phrase: "2135-2148"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 45."
Processing 00000000.tx.541: Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. 

Phrase: "Derijard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hibi,"

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "I.-H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021966:I- [Inorganic Chemical]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Barrett,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: J. 

Phrase: "J."
Processing 00000000.tx.543: (1994) Cell 76, 1025-1037[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 76,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1025-1037"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.544: Koya, D., and King, G. 

Phrase: "Koya,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "King,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.545: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.546: (1998) Diabetes 47, 859-866[Abstract] 47. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "859-866"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 47."
Processing 00000000.tx.547: Liu, W., Schoenkerman, A., and Lowe, W. 

Phrase: "Liu,"

Phrase: "W.,"

Phrase: "Schoenkerman,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Lowe,"

Phrase: "W."
Processing 00000000.tx.548: L., Jr. 

Phrase: "L., Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.549: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.550: J.

Phrase: "J."
Processing 00000000.tx.551: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.552: 279, E782-E790[Abstract/Free FullText] 48. 

Phrase: "279,"

Phrase: "E782-E790"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.553: Purves, T., Middlemas, A., Agthong, S., Jude, E. 

Phrase: "Purves,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Middlemas,"

Phrase: "A.,"

Phrase: "Agthong,"

Phrase: "S."

Phrase: ","

Phrase: "Jude,"

Phrase: "E."
Processing 00000000.tx.554: B., Boulton, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Boulton,"

Phrase: "A."
Processing 00000000.tx.555: J., Fernyhough, P., and Tomlinson, D. 

Phrase: "J.,"

Phrase: "Fernyhough,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tomlinson,"

Phrase: "D."
Processing 00000000.tx.556: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: (2001) FASEB J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.558: 15, 2508-2514[Abstract/Free FullText] 49. 

Phrase: "15,"

Phrase: "2508-2514"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.559: He, T.-C., Zhou, S., DaCosta, L. 

Phrase: "He,"

Phrase: "T.-C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Zhou,"

Phrase: "S."

Phrase: ","

Phrase: "DaCosta,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: T., Yu, J., Kinzler, K. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "J.,"

Phrase: "Kinzler,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.561: W., and Vogelstein, B. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.562: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.563: Natl. 

Phrase: "Natl."
Processing 00000000.tx.564: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.565: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.566: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.567: 95, 2509-2514[Abstract/Free FullText] 50. 

Phrase: "95,"

Phrase: "2509-2514"

Phrase: "[Abstract/Free FullText"

Phrase: "] 50."
Processing 00000000.tx.568: Davalli, A. 

Phrase: "Davalli,"

Phrase: "A."
Processing 00000000.tx.569: M., Ogawa, Y., Scaglia, L., Wu, Y.J., Hollister, J., Bonner-Weir, S., and Weir, G. 

Phrase: "M."

Phrase: ","

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "Y.,"

Phrase: "Scaglia,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Y.J.,"

Phrase: "Hollister,"

Phrase: "J.,"

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.570: C. 

Phrase: "C."
Processing 00000000.tx.571: (1995) Diabetes 44, 104-111[Abstract] 51. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Diabetes 44,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "104-111"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 51."
Processing 00000000.tx.572: Marshall, S., Bacote, V., and Traxinger, R. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Bacote,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Traxinger,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.573: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.574: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.575: Biol. 

Phrase: "Biol."
Processing 00000000.tx.576: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.577: 266, 4706-4712[Abstract/Free FullText] 52. 

Phrase: "266,"

Phrase: "4706-4712"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.578: Marshall, S., Bacote, V., and Traxinger, R. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Bacote,"

Phrase: "V.,"

Phrase: "and"

Phrase: "Traxinger,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.580: (1991) FASEB J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.581: 5, 3031-3036[Abstract/Free FullText] 53. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3031-3036"

Phrase: "[Abstract/Free FullText"

Phrase: "] 53."
Processing 00000000.tx.582: Hebert, L. 

Phrase: "Hebert,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.583: F., Daniel, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Daniel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.584: C., Zhou, J., Crook, E. 

Phrase: "C., Zhou,"

Phrase: "J.,"

Phrase: "Crook,"

Phrase: "E."
Processing 00000000.tx.585: D., Turner, R. 

Phrase: "D."

Phrase: ","

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: L., Simmons, S. 

Phrase: "L., Simmons,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.587: T., Neidigh, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Neidigh,"

Phrase: "J."
Processing 00000000.tx.588: L., Zhu, J.-S., Baron, A. 

Phrase: "L., Zhu,"

Phrase: "J.-S.,"

Phrase: "Baron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331778:Baron [Health Care Related Organization]

Phrase: "A."
Processing 00000000.tx.589: D., and McClain, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "McClain,"

Phrase: "D."
Processing 00000000.tx.590: A. 

Phrase: "A."
Processing 00000000.tx.591: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.592: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.593: Invest. 

Phrase: "Invest."
Processing 00000000.tx.594: 98, 930-936[Abstract/Free FullText] 54. 

Phrase: "98,"

Phrase: "930-936"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.595: Veerababu, G., Tang, J., Hoffman, R. 

Phrase: "Veerababu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tang,"

Phrase: "J.,"

Phrase: "Hoffman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.596: T., Daniel, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Daniel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: C., Hebert, L, F., Crook, E. 

Phrase: "C., Hebert,"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "E."
Processing 00000000.tx.598: D., Cooksey, R. 

Phrase: "D."

Phrase: ","

Phrase: "Cooksey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: C., and McClain, D. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "McClain,"

Phrase: "D."
Processing 00000000.tx.600: A. 

Phrase: "A."
Processing 00000000.tx.601: (2000) Diabetes 49, 2070-2078[Abstract] 55. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Diabetes 49,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "2070-2078"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.602: Hart, G. 

Phrase: "Hart,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.603: W. 

Phrase: "W."
Processing 00000000.tx.604: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.605: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.606: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.607: 66, 315-335[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "66,"

Phrase: "315-335"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.608: Comer, F.-I., and Hart, G. 

Phrase: "Comer,"

Phrase: "F.-I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Hart,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.609: W. 

Phrase: "W."
Processing 00000000.tx.610: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.611: Biol. 

Phrase: "Biol."
Processing 00000000.tx.612: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.613: 22, 29179-29182[CrossRef] 57. 

Phrase: "22,"

Phrase: "29179-29182"

Phrase: "[CrossRef"

Phrase: "] 57."
Processing 00000000.tx.614: Stoffers, D. 

Phrase: "Stoffers,"

Phrase: "D."
Processing 00000000.tx.615: A., Ferrer, J., Clarke, W. 

Phrase: "A.,"

Phrase: "Ferrer,"

Phrase: "J.,"

Phrase: "Clarke,"

Phrase: "W."
Processing 00000000.tx.616: L., and Habener, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.617: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.618: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.619: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.620: 17, 138-139[Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "17,"

Phrase: "138-139"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.621: Chow, C.-W., Rincon, M., Cavanagh, J., Dickens, M., and Davis, R. 

Phrase: "Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "C.-W., Rincon,"

Phrase: "M."

Phrase: ","

Phrase: "Cavanagh,"

Phrase: "J.,"

Phrase: "Dickens,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.622: J. 

Phrase: "J."
Processing 00000000.tx.623: (1997) Science 278, 1638-1641[Abstract/Free FullText] 59. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 278,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1638-1641"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.624: Elrick, L. 

Phrase: "Elrick,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.625: J., and Docherty, K. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Docherty,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.626: (2001) Diabetes 50, 2244-2252[Abstract/Free FullText] 60. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "2244-2252"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.627: Maki, A., Berezesky, I. 

Phrase: "Maki,"

Phrase: "A.,"

Phrase: "Berezesky,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.628: K., Fargnoli, J., Holbrook, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fargnoli,"

Phrase: "J.,"

Phrase: "Holbrook,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.629: J., and Trump, B. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Trump,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.630: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.631: (1992) FASEB J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.632: 6, 919-924[Abstract/Free FullText] 61. 

Phrase: "6,"

Phrase: "919-924"

Phrase: "[Abstract/Free FullText"

Phrase: "] 61."
Processing 00000000.tx.633: Li, D. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "D."
Processing 00000000.tx.634: W., and Spector, A. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Spector,"

Phrase: "A."
Processing 00000000.tx.635: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.636: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.637: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.638: 173, 59-69[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "173,"

Phrase: "59-69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.639: Inagaki, N., Maekawa, T., Sudo, T., Ishii, S., Seino, Y., and Imura, H. 

Phrase: "Inagaki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Maekawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sudo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ishii,"

Phrase: "S."

Phrase: ","

Phrase: "Seino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Imura,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.640: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.641: Natl. 

Phrase: "Natl."
Processing 00000000.tx.642: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.643: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.644: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.645: 89, 1045-1049[Abstract] 63. 

Phrase: "89,"

Phrase: "1045-1049"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 63."
Processing 00000000.tx.646: Henderson, E., and Stein, R. 

Phrase: "Henderson,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.647: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.648: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.649: Biol. 

Phrase: "Biol."
Processing 00000000.tx.650: 14, 655-662[Abstract] 64. 

Phrase: "14,"

Phrase: "655-662"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 64."
Processing 00000000.tx.651: Robinson, G. 

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.652: L.W.G., Henderson, E., Massari, M. 

Phrase: "L.W.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439294:l g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "Henderson,"

Phrase: "E.,"

Phrase: "Massari,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.653: E., Murre, C., and Stein, R. 

Phrase: "E.,"

Phrase: "Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.654: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.655: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.656: Biol. 

Phrase: "Biol."
Processing 00000000.tx.657: 15, 1398-1404[Abstract] 65. 

Phrase: "15,"

Phrase: "1398-1404"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.658: Jonas, J.-C., Laybutt, D. 

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "J.-C., Laybutt,"

Phrase: "D."
Processing 00000000.tx.659: R., Steil, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Steil,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.660: M., Trivedi, N., Pertusa, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trivedi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pertusa,"

Phrase: "J."
Processing 00000000.tx.661: G., Casteele, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Casteele,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.662: V.D., Weir, G. 

Phrase: "V.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231965:V D [Laboratory or Test Result]

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.663: C., and Henquin, J.-C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Henquin,"

Phrase: "J.-C."
Processing 00000000.tx.664: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.665: Biol. 

Phrase: "Biol."
Processing 00000000.tx.666: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.667: 276, 35375-35381[Abstract/Free FullText] 66. 

Phrase: "276,"

Phrase: "35375-35381"

Phrase: "[Abstract/Free FullText"

Phrase: "] 66."
Processing 00000000.tx.668: Kaneto, H., Suzuma, K., Sharma, A., Bonner-Weir, S., King, G. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuma,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "King,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.669: L., and Weir, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.670: C. 

Phrase: "C."
Processing 00000000.tx.671: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.672: Biol. 

Phrase: "Biol."
Processing 00000000.tx.673: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.674: 277, 3680-3685[Abstract/Free FullText] 67. 

Phrase: "277,"

Phrase: "3680-3685"

Phrase: "[Abstract/Free FullText"

Phrase: "] 67."
Processing 00000000.tx.675: Kaneto, H., Sharma, A., Suzuma, K., Laybutt, D. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "A.,"

Phrase: "Suzuma,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Laybutt,"

Phrase: "D."
Processing 00000000.tx.676: R., Xu, G., Bonner-Weir, S., and Weir, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.677: C. 

Phrase: "C."
Processing 00000000.tx.678: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.679: Biol. 

Phrase: "Biol."
Processing 00000000.tx.680: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.681: 277, 12998-13006[Abstract/Free FullText] 68. 

Phrase: "277,"

Phrase: "12998-13006"

Phrase: "[Abstract/Free FullText"

Phrase: "] 68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.682: Welsh, M., Nielsen, D. 

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Nielsen,"

Phrase: "D."
Processing 00000000.tx.683: A., MacKrell, A. 

Phrase: "A.,"

Phrase: "MacKrell,"

Phrase: "A."
Processing 00000000.tx.684: J., and Steiner, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Steiner,"

Phrase: "D."
Processing 00000000.tx.685: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.686: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Biol. 

Phrase: "Biol."
Processing 00000000.tx.688: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.689: 260, 13590-13594[Abstract/Free FullText] 69. 

Phrase: "260,"

Phrase: "13590-13594"

Phrase: "[Abstract/Free FullText"

Phrase: "] 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.690: Corbett, J. 

Phrase: "Corbett,"

Phrase: "J."
Processing 00000000.tx.691: A., Wang, J. 

Phrase: "A.,"

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.692: L., Sweetland, M. 

Phrase: "L., Sweetland,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.693: A., Lancaster, J. 

Phrase: "A.,"

Phrase: "Lancaster,"

Phrase: "J."
Processing 00000000.tx.694: R., Jr., and McDaniel, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "McDaniel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.695: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.696: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.697: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.698: Invest. 

Phrase: "Invest."
Processing 00000000.tx.699: 90, 2384-2391[Medline] [OrderarticleviaInfotrieve] 70. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2384-2391"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 70."
Processing 00000000.tx.700: Eizirik, D. 

Phrase: "Eizirik,"

Phrase: "D."
Processing 00000000.tx.701: L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. 

Phrase: "L., Sandler,"

Phrase: "S."

Phrase: ","

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cetkovic-Cvrlje,"

Phrase: "M."

Phrase: ","

Phrase: "Nieman,"

Phrase: "A.,"

Phrase: "Geller,"

Phrase: "D."
Processing 00000000.tx.702: A., Pipeleers, D. 

Phrase: "A.,"

Phrase: "Pipeleers,"

Phrase: "D."
Processing 00000000.tx.703: G., Bendten, K., and Nellerstrom. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bendten,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nellerstrom."
Processing 00000000.tx.704: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.705: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.706: Invest. 

Phrase: "Invest."
Processing 00000000.tx.707: 93, 1968-1974[Medline] [OrderarticleviaInfotrieve] 71. 

Phrase: "93,"

Phrase: "1968-1974"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.708: Ankarcrona, M., Dypbukt, J. 

Phrase: "Ankarcrona,"

Phrase: "M."

Phrase: ","

Phrase: "Dypbukt,"

Phrase: "J."
Processing 00000000.tx.709: M., Brune, B., and Nicotera, P. 

Phrase: "M."

Phrase: ","

Phrase: "Brune,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Nicotera,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.710: (1994) Exp. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.711: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.712: 213, 172-177[CrossRef][Medline] [OrderarticleviaInfotrieve] 72. 

Phrase: "213,"

Phrase: "172-177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 72."
Processing 00000000.tx.713: Kaneto, H., Fujii, J., Seo, H. 

Phrase: "Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujii,"

Phrase: "J.,"

Phrase: "Seo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.714: G., Suzuki, K., Matsuoka, T., Nakamura, M., Tatsumi, H., Yamasaki, Y., Kamada, T., and Taniguchi, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuoka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "M."

Phrase: ","

Phrase: "Tatsumi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "Kamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.715: (1995) Diabetes 44, 733-738[Abstract] 73. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Diabetes 44,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "733-738"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 73."
Processing 00000000.tx.716: Delaney, C. 

Phrase: "Delaney,"

Phrase: "C."
Processing 00000000.tx.717: A., Pavlovic, D., Hoorens, A., Pipeleers, D. 

Phrase: "A.,"

Phrase: "Pavlovic,"

Phrase: "D."

Phrase: ","

Phrase: "Hoorens,"

Phrase: "A.,"

Phrase: "Pipeleers,"

Phrase: "D."
Processing 00000000.tx.718: G., and Eizirik, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Eizirik,"

Phrase: "D."
Processing 00000000.tx.719: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.720: (1997) Endocrinology 138, 2610-2614[Abstract/Free FullText] 74. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Endocrinology 138,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "2610-2614"

Phrase: "[Abstract/Free FullText"

Phrase: "] 74."
Processing 00000000.tx.721: Ammendrup, A., Maillard, A., Nielsen, K., Anderson, A. 

Phrase: "Ammendrup,"

Phrase: "A.,"

Phrase: "Maillard,"

Phrase: "A.,"

Phrase: "Nielsen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "A."
Processing 00000000.tx.722: N., Serup, P., Madsen, O. 

Phrase: "N., Serup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Madsen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.723: D., Mandrup-Poulsen, T., and Bonny, C. 

Phrase: "D."

Phrase: ","

Phrase: "Mandrup-Poulsen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Bonny,"

Phrase: "C."
Processing 00000000.tx.724: (2000) Diabetes 49, 1468-1476[Abstract] 75. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Diabetes 49,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1468-1476"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 75."
Processing 00000000.tx.725: Bonny, C., Oberson, A., Steinmann, M., Schorderet, D. 

Phrase: "Bonny,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Oberson,"

Phrase: "A.,"

Phrase: "Steinmann,"

Phrase: "M."

Phrase: ","

Phrase: "Schorderet,"

Phrase: "D."
Processing 00000000.tx.726: F., Nicod, P., and Waeber, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nicod,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Waeber,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.727: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.728: Biol. 

Phrase: "Biol."
Processing 00000000.tx.729: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.730: 275, 16466-16472[Abstract/Free FullText] 76. 

Phrase: "275,"

Phrase: "16466-16472"

Phrase: "[Abstract/Free FullText"

Phrase: "] 76."
Processing 00000000.tx.731: Mandrup-Poulsen, T. 

Phrase: "Mandrup-Poulsen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.732: (2001) Diabetes 50, 58-63 77. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "58-63 77."
Processing 00000000.tx.733: Bonny, C., Oberson, A., Negri, S., Sause, C., and Schorderet, D. 

Phrase: "Bonny,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Oberson,"

Phrase: "A.,"

Phrase: "Negri,"

Phrase: "S."

Phrase: ","

Phrase: "Sause,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Schorderet,"

Phrase: "D."
Processing 00000000.tx.734: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.735: (2001) Diabetes 50, 77-82[Abstract/Free FullText] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "77-82"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

